TREEHOUSE FOODS, INC., 10-Q filed on 11/10/2025
Quarterly Report
v3.25.3
Cover - shares
shares in Millions
 9 Months Ended
Sep. 30, 2025
Oct. 31, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2025  
Document Transition Report false  
Entity File Number 001-32504  
Entity Registrant Name TreeHouse Foods, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 20-2311383  
Entity Address, Address Line One 2021 Spring Road,  
Entity Address, Address Line Two Suite 600  
Entity Address, City or Town Oak Brook  
Entity Address, State or Province IL  
Entity Address, Postal Zip Code 60523  
City Area Code 708  
Local Phone Number 483-1300  
Title of 12(b) Security Common Stock, $0.01 par value  
Trading Symbol THS  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   50.5
Amendment Flag false  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q3  
Entity Central Index Key 0001320695  
Current Fiscal Year End Date --12-31  
v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 21.0 $ 289.6
Receivables, net 231.4 146.8
Inventories 668.2 539.3
Prepaid expenses and other current assets 48.0 34.0
Total current assets 968.6 1,009.7
Property, plant, and equipment, net 744.8 748.6
Operating lease right-of-use assets 172.8 154.4
Goodwill 1,601.4 1,819.3
Intangible assets, net 254.3 212.9
Other assets, net 34.1 35.1
Total assets 3,776.0 3,980.0
Current liabilities:    
Accounts payable 554.7 602.5
Accrued expenses 180.7 141.3
Current portion of long-term debt 13.4 1.1
Total current liabilities 748.8 744.9
Long-term debt 1,486.1 1,401.3
Operating lease liabilities 133.4 125.4
Deferred income taxes 95.3 105.8
Other long-term liabilities 49.9 53.7
Total liabilities 2,513.5 2,431.1
Commitments and contingencies (Note 16)
Stockholders' equity:    
Preferred stock, par value $0.01 per share, 10.0 shares authorized, none issued 0.0 0.0
Common stock, par value $0.01 per share, 90.0 shares authorized, 50.5 and 50.2 shares outstanding as of September 30, 2025 and December 31, 2024, respectively 0.6 0.6
Treasury stock (385.4) (385.4)
Additional paid-in capital 2,249.5 2,238.4
Accumulated deficit (522.5) (222.0)
Accumulated other comprehensive loss (79.7) (82.7)
Total stockholders' equity 1,262.5 1,548.9
Total liabilities and stockholders' equity $ 3,776.0 $ 3,980.0
v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2025
Dec. 31, 2024
Statement of Financial Position [Abstract]    
Preferred stock, par value (in usd per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 10,000,000.0 10,000,000.0
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (in usd per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 90,000,000.0 90,000,000.0
Common stock, shares outstanding (in shares) 50,500,000 50,200,000
v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net sales $ 840.3 $ 839.1 $ 2,430.3 $ 2,448.3
Cost of sales 682.4 707.9 2,018.0 2,076.8
Gross profit 157.9 131.2 412.3 371.5
Operating expenses:        
Selling and distribution 36.8 36.0 108.2 114.4
General and administrative 45.3 46.0 152.3 156.0
Amortization expense 13.0 12.3 39.3 36.5
Impairment 289.7 0.0 289.7 19.3
Other operating expense, net 27.2 5.1 55.1 22.7
Total operating expenses 412.0 99.4 644.6 348.9
Operating (loss) income (254.1) 31.8 (232.3) 22.6
Other expense:        
Interest expense 23.9 16.0 65.4 47.2
Interest income (0.2) (0.1) (3.2) (4.2)
Loss on extinguishment of debt 0.0 0.0 2.6 0.0
Loss (gain) on foreign currency exchange 1.8 (1.7) (3.2) 3.2
Other (income) expense, net (12.1) 21.9 22.8 16.9
Total other expense 13.4 36.1 84.4 63.1
Loss before income taxes (267.5) (4.3) (316.7) (40.5)
Income tax benefit (1.7) (0.9) (16.2) (8.7)
Net loss $ (265.8) $ (3.4) $ (300.5) $ (31.8)
Loss per common share:        
Basic (in dollars per share) $ (5.26) $ (0.07) $ (5.95) $ (0.60)
Diluted (in dollars per share) $ (5.26) $ (0.07) $ (5.95) $ (0.60)
Weighted average common shares:        
Basic (in shares) 50.5 51.9 50.5 52.7
Diluted (in shares) 50.5 51.9 50.5 52.7
v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Statement of Comprehensive Income [Abstract]        
Net loss $ (265.8) $ (3.4) $ (300.5) $ (31.8)
Other comprehensive (loss) income:        
Foreign currency translation adjustments (1.6) 1.5 3.1 (2.4)
Pension and postretirement reclassification adjustment 0.0 0.0 (0.1) 0.0
Other comprehensive (loss) income (1.6) 1.5 3.0 (2.4)
Comprehensive loss $ (267.4) $ (1.9) $ (297.5) $ (34.2)
v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2023   59.3        
Beginning balance at Dec. 31, 2023 $ 1,664.8 $ 0.6 $ (234.2) $ 2,223.4 $ (248.9) $ (76.1)
Treasury stock, beginning balance (in shares) at Dec. 31, 2023     (5.2)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (11.7)       (11.7)  
Other comprehensive (loss) income (2.6)         (2.6)
Treasury stock repurchases (in shares)     (1.2)      
Treasury stock repurchases (44.3)   $ (44.3)      
Issuance of stock awards (in shares)   0.2        
Issuance of stock awards (3.8)     (3.8)    
Stock-based compensation 5.7     5.7    
Ending balance (in shares) at Mar. 31, 2024   59.5        
Ending balance at Mar. 31, 2024 1,608.1 $ 0.6 $ (278.5) 2,225.3 (260.6) (78.7)
Treasury stock, ending balance (in shares) at Mar. 31, 2024     (6.4)      
Beginning balance (in shares) at Dec. 31, 2023   59.3        
Beginning balance at Dec. 31, 2023 1,664.8 $ 0.6 $ (234.2) 2,223.4 (248.9) (76.1)
Treasury stock, beginning balance (in shares) at Dec. 31, 2023     (5.2)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (31.8)          
Other comprehensive (loss) income $ (2.4)          
Treasury stock repurchases (in shares) (2.5)          
Ending balance (in shares) at Sep. 30, 2024   59.6        
Ending balance at Sep. 30, 2024 $ 1,552.6 $ 0.6 $ (323.7) 2,234.9 (280.7) (78.5)
Treasury stock, ending balance (in shares) at Sep. 30, 2024     (7.7)      
Beginning balance (in shares) at Mar. 31, 2024   59.5        
Beginning balance at Mar. 31, 2024 1,608.1 $ 0.6 $ (278.5) 2,225.3 (260.6) (78.7)
Treasury stock, beginning balance (in shares) at Mar. 31, 2024     (6.4)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (16.7)       (16.7)  
Other comprehensive (loss) income (1.3)         (1.3)
Treasury stock repurchases (in shares)     (1.3)      
Treasury stock repurchases (45.2)   $ (45.2)      
Issuance of stock awards (0.1)     (0.1)    
Stock-based compensation 5.3     5.3    
Ending balance (in shares) at Jun. 30, 2024   59.5        
Ending balance at Jun. 30, 2024 1,550.1 $ 0.6 $ (323.7) 2,230.5 (277.3) (80.0)
Treasury stock, ending balance (in shares) at Jun. 30, 2024     (7.7)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (3.4)       (3.4)  
Other comprehensive (loss) income $ 1.5         1.5
Treasury stock repurchases (in shares) 0.0          
Issuance of stock awards (in shares)   0.1        
Issuance of stock awards $ (0.1)     (0.1)    
Stock-based compensation 4.5     4.5    
Ending balance (in shares) at Sep. 30, 2024   59.6        
Ending balance at Sep. 30, 2024 $ 1,552.6 $ 0.6 $ (323.7) 2,234.9 (280.7) (78.5)
Treasury stock, ending balance (in shares) at Sep. 30, 2024     (7.7)      
Beginning balance (in shares) at Dec. 31, 2024 50.2 59.5        
Beginning balance at Dec. 31, 2024 $ 1,548.9 $ 0.6 $ (385.4) 2,238.4 (222.0) (82.7)
Treasury stock, beginning balance (in shares) at Dec. 31, 2024     (9.3)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (31.8)       (31.8)  
Other comprehensive (loss) income 0.2         0.2
Issuance of stock awards (in shares)   0.2        
Issuance of stock awards (4.0)     (4.0)    
Stock-based compensation 5.6     5.6    
Ending balance (in shares) at Mar. 31, 2025   59.7        
Ending balance at Mar. 31, 2025 $ 1,518.9 $ 0.6 $ (385.4) 2,240.0 (253.8) (82.5)
Treasury stock, ending balance (in shares) at Mar. 31, 2025     (9.3)      
Beginning balance (in shares) at Dec. 31, 2024 50.2 59.5        
Beginning balance at Dec. 31, 2024 $ 1,548.9 $ 0.6 $ (385.4) 2,238.4 (222.0) (82.7)
Treasury stock, beginning balance (in shares) at Dec. 31, 2024     (9.3)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (300.5)          
Other comprehensive (loss) income $ 3.0          
Treasury stock repurchases (in shares) 0.0          
Ending balance (in shares) at Sep. 30, 2025 50.5 59.8        
Ending balance at Sep. 30, 2025 $ 1,262.5 $ 0.6 $ (385.4) 2,249.5 (522.5) (79.7)
Treasury stock, ending balance (in shares) at Sep. 30, 2025     (9.3)      
Beginning balance (in shares) at Mar. 31, 2025   59.7        
Beginning balance at Mar. 31, 2025 1,518.9 $ 0.6 $ (385.4) 2,240.0 (253.8) (82.5)
Treasury stock, beginning balance (in shares) at Mar. 31, 2025     (9.3)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (2.9)       (2.9)  
Other comprehensive (loss) income 4.4         4.4
Issuance of stock awards (in shares)   0.1        
Issuance of stock awards (0.1)     (0.1)    
Stock-based compensation 4.8     4.8    
Ending balance (in shares) at Jun. 30, 2025   59.8        
Ending balance at Jun. 30, 2025 1,525.1 $ 0.6 $ (385.4) 2,244.7 (256.7) (78.1)
Treasury stock, ending balance (in shares) at Jun. 30, 2025     (9.3)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (265.8)       (265.8)  
Other comprehensive (loss) income $ (1.6)         (1.6)
Treasury stock repurchases (in shares) 0.0          
Stock-based compensation $ 4.8     4.8    
Ending balance (in shares) at Sep. 30, 2025 50.5 59.8        
Ending balance at Sep. 30, 2025 $ 1,262.5 $ 0.6 $ (385.4) $ 2,249.5 $ (522.5) $ (79.7)
Treasury stock, ending balance (in shares) at Sep. 30, 2025     (9.3)      
v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (300.5) $ (31.8)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 125.2 109.5
Impairment 289.7 19.3
Stock-based compensation 15.2 15.5
Loss on extinguishment of debt 2.6 0.0
Unrealized loss on derivative contracts 19.0 11.0
Deferred income taxes (14.7) (4.0)
Other, net 2.5 8.4
Changes in operating assets and liabilities, net of acquisitions:    
Receivables (70.2) (48.8)
Inventories (85.0) (84.4)
Prepaid expenses and other assets (13.4) (19.7)
Accounts payable (50.6) 7.2
Accrued expenses and other liabilities 17.7 (12.6)
Net cash used in operating activities (62.5) (30.4)
Cash flows from investing activities:    
Capital expenditures (84.8) (91.6)
Proceeds from sales of fixed assets 12.7 1.4
Acquisition, net of cash acquired (209.3) 0.0
Net cash used in investing activities (281.4) (90.2)
Cash flows from financing activities:    
Borrowings under Revolving Credit Facility 2,251.9 212.5
Payments under Revolving Credit Facility (2,156.9) (212.5)
Payments on financing lease obligations (1.6) (0.6)
Deferred payment from acquisition of seasoned pretzel capability 0.0 (4.0)
Payment of deferred financing costs (3.9) 0.0
Payments on Term Loans (907.1) 0.0
Proceeds from refinanced Term Loans 899.2 0.0
Payments on insurance premium financing (1.7) 0.0
Repurchases of common stock 0.0 (88.7)
Payments related to stock-based award activities (4.1) (4.0)
Net cash provided by (used in) financing activities 75.8 (97.3)
Effect of exchange rate changes on cash and cash equivalents (0.5) (0.4)
Net decrease in cash and cash equivalents (268.6) (218.3)
Cash and cash equivalents, beginning of period 289.6 320.3
Cash and cash equivalents, end of period 21.0 102.0
Supplemental cash flow disclosures:    
Interest paid 76.9 69.6
Net income taxes paid 17.3 5.7
Non-cash investing and financing activities:    
Capital expenditures incurred but not yet paid 9.9 21.5
Right-of-use assets obtained in exchange for lease obligations 44.6 3.3
Preliminary purchase price adjustment for private brand tea business acquisition 2.0 0.0
Accrued deferred financing costs 0.0 0.2
Financed insurance premium exchanged for prepaid insurance $ 9.4 $ 0.0
v3.25.3
BASIS OF PRESENTATION
 9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
BASIS OF PRESENTATION
1. BASIS OF PRESENTATION

The unaudited Condensed Consolidated Financial Statements included herein have been prepared by TreeHouse Foods, Inc. and its consolidated subsidiaries (the "Company," "TreeHouse," "we," "us," or "our"), pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") applicable to quarterly reporting on Form 10-Q. In our opinion, these statements include all adjustments necessary for a fair presentation of the results of all interim periods reported herein. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted as permitted by such rules and regulations. The Condensed Consolidated Financial Statements and related notes should be read in conjunction with the Consolidated Financial Statements and related notes included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Results of operations for interim periods are not necessarily indicative of annual results.

Use of Estimates

The preparation of our Condensed Consolidated Financial Statements in conformity with GAAP requires management to use judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements, and the reported amounts of net sales and expenses during the reporting period. Actual results could differ from these estimates.

Summary of Significant Accounting Policies

A detailed description of the Company's significant accounting policies can be found in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
v3.25.3
RECENT ACCOUNTING PRONOUNCEMENTS
 9 Months Ended
Sep. 30, 2025
Accounting Changes and Error Corrections [Abstract]  
RECENT ACCOUNTING PRONOUNCEMENTS
2. RECENT ACCOUNTING PRONOUNCEMENTS

Not yet adopted

In September 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. ASU 2025-06 modernizes the guidance for accounting for software costs by removing all references to software development project stages and clarifying criteria for capitalization. The amendment is effective for annual periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the provisions of the amendments and the effect on its future Consolidated Financial Statements.

In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. These amendments require disclosure of the election of a practical expedient that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset when estimating expected credit losses for current accounts receivable and current contract assets. The amendments are effective for annual periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. The Company is currently evaluating the provisions of the amendments and the effect on its future Consolidated Financial Statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, and in January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. ASU 2024-03 requires additional information about specific expenses in certain notes to the Consolidated Financial Statements. The new guidance in ASU 2024-03, as clarified by ASU 2025-01, will be effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. Upon adoption, the impact of ASU 2024-03 will be limited to certain notes to the Consolidated Financial Statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to enhance the transparency and decision usefulness of income tax disclosures. The amendments are effective for annual periods beginning after December 15, 2024 on a prospective basis. Early adoption is permitted. Upon adoption, the impact of ASU 2023-09 will be limited to certain notes to the Consolidated Financial Statements.
v3.25.3
RESTRUCTURING PROGRAMS
 9 Months Ended
Sep. 30, 2025
Restructuring and Related Activities [Abstract]  
RESTRUCTURING PROGRAMS
3. RESTRUCTURING PROGRAMS

The Company’s restructuring and margin improvement activities are part of an enterprise-wide transformation to improve long-term profitability of the Company. These activities are aggregated into two activities: (1) Organizational restructuring and (2) Facility closures (collectively the "Restructuring Programs").

The costs by activity for the Restructuring Programs are outlined below:

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
(In millions)
Organizational restructuring$20.8 $3.1 $46.3 $16.9 
Facility closures13.23.721.68.1
Total$34.0 $6.8 $67.9 $25.0 
Below is a summary of costs by line item for the Restructuring Programs:

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
(In millions)
Cost of sales$6.7 $1.7 $12.4 $1.7 
Other operating expense, net27.3 5.1 55.5 23.3 
Total$34.0 $6.8 $67.9 $25.0 

The table below presents the exit cost liability related to severance activity for the Restructuring Programs as of September 30, 2025:
 Severance
 (In millions)
Balance as of December 31, 2024$1.8 
Expenses recognized19.5 
Cash payments(7.0)
Balance as of September 30, 2025$14.3 
 
The severance liabilities are included in Accrued expenses in the Condensed Consolidated Balance Sheets.

(1) Organizational restructuring

Organizational restructuring activities primarily relate to professional fees, consulting services, retention costs, severance costs, organizational redesign activities, information technology system implementation, and other costs associated with ongoing restructuring and exit activities.

In April 2025, the Company announced a restructuring of our current business, including a reorganization of our corporate support functions, to drive greater operational efficiency, achieve significant cost-savings, and enhance profitability and cash flow, while improving quality and service levels. This resulted in fees related to consulting services and employee-related severance costs.

Below is a summary of costs by type associated with organizational restructuring activities:

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
(In millions)
Asset-related$— $— $1.4 $— 
Employee-related10.4 0.2 19.2 7.5 
Other costs10.4 2.9 25.7 9.4 
Total$20.8 $3.1 $46.3 $16.9 

For the three and nine months ended September 30, 2025 and 2024, asset-related costs primarily consisted of accelerated depreciation; employee-related costs primarily consisted of severance and retention related to restructuring programs; and other costs primarily consisted of consulting services. Asset-related costs are recognized in Cost of sales, and employee-related and other costs are recognized in Other operating expense, net in the Condensed Consolidated Statements of Operations.
(2) Facility closures

The Company continually analyzes its plant network to align operations with the current and future needs of its customers. Facility closure decisions are made when the Company identifies opportunities to lower production costs or eliminate excess manufacturing capacity through consolidation while maintaining a competitive cost structure, service levels, and product quality. The key information regarding the Company’s announced facility closures is outlined in the table below.

Facility LocationDate Closure AnnouncedEnd of ProductionPrimary Products ProducedCumulative Costs to DateTotal Expected Costs
Chicago, IllinoisQ3 2025Expected Q4 2025Pickles$2.8 $6.0 
South Beloit, IllinoisQ3 2025Expected H1 2026Cookies4.3 14.0 
New Hampton, Iowa (1)Q1 2025Q3 2025Non-dairy creamer ("NDC")10.8 12.0 
Dallas, Texas (2)Q4 2023Q4 2023Single-serve beverage ("SSB") / Coffee13.7 14.0 
$31.6 $46.0 

(1)During the third quarter of 2025, the Company completed the sale of the New Hampton, Iowa facility for $7.9 million, and the Company consolidated its NDC production into two existing facilities: Wayland, Michigan, and Pecatonica, Illinois.
(2)During the fourth quarter of 2023, the Company completed the closure of its Dallas, Texas Coffee facility in connection with the integration of the Coffee Roasting Capability and transitioned production from Dallas to its Northlake, Texas facility during the first half of 2024. As the Company continued related integration activities, the Company exited a distribution center in Grand Prairie, Texas, during the third quarter of 2024. As a result of this distribution center exit, an impairment of $0.9 million of Operating lease right-of-use assets was recognized in our Grand Prairie asset group in the third quarter of 2024.

Ready-to-drink Business Exit — During the second quarter of 2024, the Company made the decision to exit the Ready-to-drink ("RTD") business as part of the Company's portfolio optimization strategy to focus on higher-growth, higher margin categories. During the first quarter of 2025, production for the RTD business ceased, and the Company sold the related machinery and equipment. The total costs related to the business exit are expected to be approximately $4.0 million, and the cumulative costs incurred to date are $3.9 million. These costs include the decommissioning and disposal of related assets and inventory, as well as other transitioning costs. The costs for the three and nine months ended September 30, 2025 were $0.5 million and $2.0 million, respectively. Refer to Note 7 for additional information regarding the impairment of the RTD asset group in the second quarter of 2024.

Below is a summary of costs by type associated with the facility closures:

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
(In millions)
Asset-related$4.9 $2.6 $9.4 $2.6 
Employee-related3.8 0.2 5.4 0.2 
Other costs4.5 0.9 6.8 5.3 
Total$13.2 $3.7 $21.6 $8.1 
 
For the three and nine months ended September 30, 2025 and 2024, asset-related costs consisted of accelerated depreciation, inventory write-downs, operating lease right-of-use asset impairment, and loss on disposals of property, plant, and equipment; employee-related costs primarily consisted of severance and retention related to restructuring programs; other costs primarily consisted of third party and associated costs related to facility plant closures. Asset-related and other costs are recognized in Cost of sales and Other operating expense, net, and employee-related costs are recognized in Other operating expense, net in the Condensed Consolidated Statements of Operations.
v3.25.3
RECEIVABLES SALES PROGRAM
 9 Months Ended
Sep. 30, 2025
Receivables [Abstract]  
RECEIVABLES SALES PROGRAM
4. RECEIVABLES SALES PROGRAM
 
The Company has entered into an agreement to sell certain trade accounts receivable to an unrelated, third-party financial institution at a discount (collectively, the "Receivables Sales Program"). The agreement can be terminated by either party with 60 days' notice. The Receivables Sales Program is used by the Company to manage liquidity in a cost-effective manner. The Company has no retained interest in the receivables sold under the Receivables Sales Program; however, under the agreement, the Company does have collection and administrative responsibilities for the sold receivables. Under the Receivables Sales Program, the current operating limit of outstanding accounts receivables sold at any time is $397.5 million.

The following table includes the outstanding amount of accounts receivable sold under the Receivables Sales Program and the receivables collected from customers and not remitted to the financial institution that is included within outstanding accounts receivables sold:
September 30, 2025December 31, 2024
 (In millions)
Outstanding accounts receivable sold$221.7 $375.0 
Receivables collected and not remitted to financial institution181.1 237.7 
Receivables sold under the Receivables Sales Program are derecognized from the Company's Condensed Consolidated Balance Sheets at the time of the sale and the proceeds from such sales are reflected as a component of the change in receivables in the operating activities section of the Condensed Consolidated Statements of Cash Flows. The receivables collected and not remitted to the financial institution are included in Accounts payable in the Condensed Consolidated Balance Sheets.

The following table summarizes the cash flows of the Company's accounts receivable associated with the Receivables Sales Program:
Nine Months Ended September 30,
20252024
 (In millions)
Receivables sold$855.3 $891.6 
Receivables collected and remitted to financial institution(1,008.6)(993.9)

The loss on sale of receivables represents the discount taken by the third-party financial institution and was $1.5 million and $2.7 million for the three months ended September 30, 2025 and 2024, respectively, and $5.7 million and $6.6 million for the nine months ended September 30, 2025 and 2024, respectively, and is included in Other (income) expense, net in the Condensed Consolidated Statements of Operations. The Company has not recognized any servicing assets or liabilities as of September 30, 2025 or December 31, 2024, as the fair value of the servicing arrangement as well as the fees earned were not material to the financial statements.
v3.25.3
INVENTORIES
 9 Months Ended
Sep. 30, 2025
Inventory Disclosure [Abstract]  
INVENTORIES
5. INVENTORIES

September 30, 2025December 31, 2024
 (In millions)
Raw materials and supplies$222.7 $217.4 
Finished goods445.5 321.9 
Total inventories$668.2 $539.3 
v3.25.3
ACQUISITIONS
 9 Months Ended
Sep. 30, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
ACQUISITIONS
6. ACQUISITIONS

Acquisition of Private Brand Tea Business

On January 2, 2025, the Company completed the acquisition of certain subsidiaries that operate the private brand tea business of Harris Freeman & Co, Inc. ("Harris Tea"), a leading private brand tea manufacturer in the U.S., for approximately $207.6 million in cash, subject to customary purchase price adjustments. In addition to private brand tea, Harris Tea manufactures specialty retail tea brands and foodservice tea products for the restaurant and hospitality industries. The acquisition aligns with our long-term strategy to build capabilities in our higher-growth, higher-margin categories.

The acquisition is being accounted for under the acquisition method of accounting, and the results of operations were included in our Condensed Consolidated Financial Statements from the date of acquisition. Included in the Company’s Condensed Consolidated Statements of Operations are Harris Tea’s net sales of approximately $110.6 million and income before income taxes of $8.1 million from the date of acquisition through September 30, 2025. The Company incurred approximately $3.4 million in acquisition-related costs, of which $0.2 million and $0.7 million were incurred during the three and nine months ended September 30, 2025, respectively. These costs are included in General and administrative in the Condensed Consolidated Statements of Operations.

The following table summarizes the preliminary purchase price allocation of the fair value of net tangible and intangible assets acquired and liabilities assumed:
(In millions)
Cash transferred at close
$209.6 
Preliminary purchase price adjustment
(2.0)
Total consideration transferred$207.6 
Allocation of consideration to assets acquired and liabilities assumed:
Cash
$0.3 
Receivables
11.4 
Inventories41.8 
Property, plant, and equipment
19.0 
Operating lease right-of-use assets
25.7 
Goodwill69.7 
Customer relationships65.0 
Trademarks
12.9 
Other assets0.6 
Assets acquired246.4 
Assumed liabilities(38.8)
Total purchase price$207.6 

The acquired receivables includes gross amounts due of $11.4 million which were determined to be collectible. The operating lease right-of-use assets acquired of $25.7 million includes a $6.5 million off-market lease fair value adjustment. The intangible assets acquired include $65.0 million of customer relationships with an estimated life of 20 years and $12.9 million of trademarks with an estimated life of 10 years. The aforementioned intangible assets will be amortized over their estimated useful lives. The Company increased the cost of acquired inventories by approximately $1.9 million and expensed this amount as a component of Cost of sales during the during the first quarter of 2025, for the amortization of the inventory fair value step up adjustment. The Company recognized $69.7 million of goodwill relating to the acquisition. The primary factors that contributed to the recognition of goodwill are growth opportunities provided by vertical integration and customer synergies from its existing coffee and tea businesses. The goodwill resulting from this acquisition is tax deductible, as it is considered an asset acquisition for tax purposes.
Personal property fair values were determined using the cost approach, and the real estate lease fair values were determined using the income approach. The fair values for customer relationships at the acquisition date were determined using the excess earnings method under the income approach, while trademark fair values were determined using the relief from royalty method. The fair value measurements of intangible assets are based on significant unobservable inputs, and thus represent Level 3 inputs. Significant assumptions used in assessing the fair values of intangible assets include discounted future cash flows, customer attrition rates, and royalty rates.

The purchase price allocation in the table above is preliminary and subject to the finalization of the Company's valuation analysis.

The following unaudited pro forma information shows the results of operations for the Company as if its Harris Tea acquisition had been completed as of January 1, 2024. Adjustments have been made for the pro forma effects of depreciation and amortization of tangible and intangible assets recognized as part of the business combination, the amortization of the inventory fair value step-up, the amortization of off-market lease adjustments, acquisition-related costs, and related income taxes. The pro forma results may not necessarily reflect actual results of operations that would have been achieved, nor are they necessarily indicative of future results of operations.

Three Months Ended September 30, 2024Nine Months Ended September 30, 2024
(Unaudited, in millions)
Pro forma net sales
$874.7 $2,554.6 
Pro forma net income (loss)— (28.1)

Acquisition of Pickle Branded Assets

On January 2, 2024, the Company completed the acquisition of pickle branded assets, including Bick’s pickles, Habitant pickled beets, Woodman’s horseradish, and McLarens pickled onions brands (the "Pickle Branded Assets"), from The J.M. Smucker Co., a North American producer of coffee, consumer foods, dog snacks, and cat food. The acquisition is consistent with our strategy and builds depth in our Pickles category by expanding into Canada. The total purchase consideration transferred was approximately $25.9 million in cash. The purchase of the Pickle Branded Assets was accounted for as an Asset Acquisition.

The following table summarizes the purchase price allocation of the fair value of net tangible and intangible assets acquired:

(In millions)
Cash transferred at close$20.0 
Purchase price adjustment5.9 
Total consideration transferred$25.9 
Allocation of consideration to assets acquired:
Inventories$25.2 
Trademarks0.7 
Total purchase price$25.9 

Intangible assets acquired included trademarks with an estimated life of 10 years.
v3.25.3
PROPERTY, PLANT, AND EQUIPMENT
 9 Months Ended
Sep. 30, 2025
Property, Plant and Equipment [Abstract]  
PROPERTY, PLANT, AND EQUIPMENT
7. PROPERTY, PLANT, AND EQUIPMENT
September 30, 2025December 31, 2024
(In millions)
Land$35.7 $35.0 
Buildings and improvements375.7 378.1 
Machinery and equipment1,092.0 1,063.3 
Construction in progress123.0 120.6 
Total1,626.4 1,597.0 
Less accumulated depreciation(881.6)(848.4)
Property, plant, and equipment, net$744.8 $748.6 

Depreciation expense was $28.7 million and $24.4 million for the three months ended September 30, 2025 and 2024, respectively, and $85.9 million and $73.0 million for the nine months ended September 30, 2025 and 2024, respectively.

Asset Impairment

We evaluate property, plant, and equipment, operating lease right-of-use assets, and finite lived intangible assets for impairment when circumstances indicate that their carrying values may not be recoverable. Indicators of impairment include deteriorations in operating cash flows, the anticipated sale or disposal of an asset group, and other significant changes in business conditions.

During the second quarter of 2024, as a result of forecasted cash flow losses, the Company made the decision to exit the RTD business. As a result, the Company performed a recoverability assessment over the RTD asset group in the second quarter of 2024, which indicated that the asset group was not recoverable, and we were required to determine the fair value of the business. Our fair value assessment indicated that the carrying value was in excess of the fair value, and an impairment of $19.3 million of property, plant, and equipment was recognized in our RTD beverages asset group. The asset impairment charge was included in Impairment in the Condensed Consolidated Statements of Operations.

Impairment charges are measured by comparing the carrying value of the asset group to its estimated fair value. The fair value of the asset group was based on expected future cash flows using Level 3 inputs under ASC 820. We can provide no assurance regarding the prospect of additional impairment charges in future periods.
v3.25.3
GOODWILL AND INTANGIBLE ASSETS
 9 Months Ended
Sep. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS
8. GOODWILL AND INTANGIBLE ASSETS
 
Goodwill

Changes in the carrying amount of goodwill for the nine months ended September 30, 2025 are as follows:
Goodwill
 (In millions)
Balance at December 31, 2024$1,819.3 
Foreign currency exchange adjustments2.1 
Acquisition69.7 
Impairment loss(289.7)
Balance at September 30, 2025$1,601.4 

During the third quarter of 2025, we concluded that the sustained decrease in our share price and market capitalization was a triggering event requiring an interim goodwill impairment assessment. We performed an interim impairment test as of the last day of our third quarter, September 30, 2025, and utilized the discounted cash flow method under the income approach to estimate the fair value of the Company, which was corroborated by the Guideline Public Company Methodology market approach. The income approach utilizes projected cash flow estimates developed by the Company to determine fair value, which are unobservable, Level 3 inputs. Unobservable inputs are used to measure fair value to the extent relevant observable inputs are not available. The Company developed our estimates using the best information available at the time. As a result of the impairment test, we recognized a non-cash goodwill impairment loss of $289.7 million.

Accumulated goodwill impairment losses were $289.7 million as of September 30, 2025.

Intangible Assets

The gross carrying amounts and accumulated amortization of intangible assets as of September 30, 2025 and December 31, 2024 are as follows:

 September 30, 2025December 31, 2024
Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount
 (In millions)
Intangible assets with finite lives:      
Customer-related$612.2 $(424.3)$187.9 $546.0 $(395.6)$150.4 
Trademarks31.3 (18.0)13.3 19.2 (17.0)2.2 
Formulas/recipes15.4 (15.2)0.2 15.4 (15.0)0.4 
Computer software190.6 (143.7)46.9 212.6 (158.7)53.9 
Total finite lived intangibles849.5 (601.2)248.3 793.2 (586.3)206.9 
Intangible assets with indefinite lives:
Trademarks6.0 — 6.0 6.0 — 6.0 
Total intangible assets$855.5 $(601.2)$254.3 $799.2 $(586.3)$212.9 
v3.25.3
INCOME TAXES
 9 Months Ended
Sep. 30, 2025
Income Tax Disclosure [Abstract]  
INCOME TAXES
9. INCOME TAXES
 
Income taxes were recognized at effective rates of 0.6% and 5.1% for the three and nine months ended September 30, 2025, respectively, compared to 20.9% and 21.5% for the three and nine months ended September 30, 2024, respectively. The change in the Company's effective tax rate for the three and nine months ended September 30, 2025 compared to 2024 is primarily driven by the impairment of goodwill and changes in the amount of executive compensation, both of which are not deductible for tax purposes. Our effective tax rate may change from period to period based on recurring and non-recurring factors, including the jurisdictional mix of earnings, enacted tax legislation, state income taxes, settlement of tax audits, and the expiration of the statute of limitations in relation to unrecognized tax benefits.

Management estimates that it is reasonably possible that the total amount of unrecognized tax benefits could decrease by as much as $0.4 million within the next 12 months, primarily as a result of the lapsing of statutes of limitations. Approximately all of the $0.4 million could affect net income when settled. The timing of cash settlement, if any, cannot be reasonably estimated for uncertain tax benefits.
v3.25.3
DEBT
 9 Months Ended
Sep. 30, 2025
Debt Disclosure [Abstract]  
DEBT
10. DEBT
 
September 30, 2025December 31, 2024
 (In millions)
Revolving Credit Facility$95.0 $— 
Term Loan A480.0 316.4 
Term Loan A-1422.9 588.6 
2028 Notes500.0 500.0 
Insurance premium financing7.7 — 
Finance leases4.1 4.1 
Total outstanding debt1,509.7 1,409.1 
Deferred financing costs(10.2)(6.7)
Less current portion(13.4)(1.1)
Total long-term debt$1,486.1 $1,401.3 

The scheduled maturities of outstanding debt, excluding deferred financing costs, at September 30, 2025 are as follows (in millions):

Remainder of 2025$4.0
202610.7
202718.1
2028522.2
202921.6
Thereafter933.1
     Total outstanding debt$1,509.7

Credit Agreement — On January 17, 2025, the Company entered into the Third Amended and Restated Credit Agreement (the "Credit Agreement"), among the Company, the lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer.

The Credit Agreement amends, restates and replaces the Company’s prior Credit Agreement, dated as of December 1, 2017 (as amended from time to time prior to January 17, 2025), pursuant to which the Company obtained a $500.0 million revolving credit facility (the "Revolving Credit Facility"), a $500.0 million term A loan (the "Term Loan A") and a $900.0 million tranche A-1 term loan (the "Term Loan A-1" and, together with the Term Loan A, the "Term Loans"). Pursuant to the Credit Agreement, the Company (i) continued and extended the maturity of the Revolving Credit Facility and the Term Loans, (ii) decreased the aggregate size of the Term Loan A to $480.0 million and (iii) decreased the aggregate size of the Term Loan A-1 to $425.0 million.
On March 14, 2025, the Company entered into Amendment No. 1 to the Credit Agreement, which amends and restates the defined term "Existing Letters of Credit." The material terms and conditions under the Credit Agreement are otherwise substantially consistent with those contained in the Credit Agreement prior to Amendment No. 1.

Loss on Extinguishment of Debt — During the first quarter of 2025, the Company incurred a loss on extinguishment of debt totaling $2.6 million representing the write-off of deferred financing costs in connection with the Credit Agreement refinancing in January 2025.

Revolving Credit Facility — As of September 30, 2025, the Company had $95.0 million drawn from its $500.0 million Revolving Credit Facility. The Company had remaining availability of $372.2 million under the Revolving Credit Facility, and there were $32.8 million in letters of credit under the Revolving Credit Facility that were issued but undrawn, which have been included as a reduction to the calculation of available credit. The Revolving Credit Facility matures on January 17, 2030.

Interest is payable in arrears the earlier of the end of the applicable interest period, quarterly, or the maturity date on any outstanding borrowings under the Revolving Credit Facility. The Revolving Credit Facility bears interest at a rate per annum equal to (i) Term SOFR plus a margin ranging from 1.25% to 2.50% based on the Company’s consolidated net leverage ratio or (ii) a Base Rate (as defined in the Credit Agreement) plus a margin ranging from 0.25% to 1.50% based on the Company’s consolidated net leverage ratio. The Company also pays an unused fee on the Revolving Credit Facility at a rate ranging from 0.20% to 0.40% based on the Company’s consolidated net leverage ratio, with the initial unused fee set at 0.30%. The Revolving Credit Facility includes sub-facilities for swing line loans and letters of credit.

The Credit Agreement is fully and unconditionally, as well as jointly and severally, guaranteed by our 100% owned direct and indirect domestic subsidiaries: Bay Valley Foods, LLC; Cottage Bakery, Inc.; Harris Tea Company LLC; Linette Quality Chocolates, Inc.; Pickles Manufacturing LLC; Protenergy Holdings, Inc.; Protenergy Natural Foods, Inc.; Ralcorp Frozen Bakery Products, Inc.; Refrigerated Dough, Inc.; Southern Tea, LLC; Sturm Foods, Inc.; TreeHouse Foods Services, LLC; TreeHouse Private Brands, Inc.; and certain other domestic subsidiaries that may become guarantors in the future, which are collectively known as the "Guarantor Subsidiaries." The Credit Agreement contains various financial and restrictive covenants and requires that the Company maintain a consolidated net leverage ratio of no greater than 4.50 to 1.0. The Credit Agreement also contains cross-default provisions which could result in the acceleration of payments in the event TreeHouse or the Guarantor Subsidiaries (i) fails to make a payment when due in respect of any indebtedness or guarantee having an aggregate principal amount greater than $75.0 million or (ii) fails to observe or perform any other agreement or condition related to such indebtedness or guarantee as a result of which the holder(s) of such debt are permitted to accelerate the payment of such debt.

Term Loan A — On January 17, 2025, the Company entered into a $480.0 million Term Loan A with a maturity date of January 17, 2030. Term Loan A bears interest at a rate per annum equal to (i) Term SOFR plus a margin ranging from 1.525% to 2.775% based on the Company’s consolidated net leverage ratio or (ii) a Base Rate (as defined in the Credit Agreement) plus a margin ranging from 0.525% to 1.775% based on the Company’s consolidated net leverage ratio; provided that the Company and Term Loan A lenders may agree to a quoted fixed rate for the Term Loan A at a future date. The principal balance is due at maturity. Interest is payable in arrears the earlier of the end of the applicable interest period, quarterly, or the maturity date on any outstanding borrowings under the Term Loan A. Term Loan A is subject to substantially the same covenants as the Revolving Credit Facility, and also has the same Guarantor Subsidiaries.

Term Loan A-1 — On January 17, 2025, the Company entered into a $425.0 million Term Loan A-1. The maturity date and interest rates applicable to Term Loan A-1 are the same as those applicable to the Revolving Credit Facility. Interest is payable in arrears the earlier of the end of the applicable interest period, quarterly, or the maturity date on any outstanding borrowings under the Term Loan A-1. Principal payments are due on a quarterly basis, beginning June 30, 2025, in an amount equal to (i) 0.25% of the $425.0 million original commitment for the first eight quarterly installments and (ii) 1.25% of the $425.0 million original commitment thereafter until maturity. Term Loan A-1 is subject to substantially the same covenants as the Revolving Credit Facility, and has the same Guarantor Subsidiaries.

2028 Notes — On September 9, 2020, the Company completed its public offering of $500 million aggregate principal amount of notes (the "2028 Notes"). The 2028 Notes pay interest at the rate of 4.000% per annum and mature on September 1, 2028. Interest is payable on the 2028 Notes on March 1 and September 1 of each year.
Insurance Premium Financing — During the third quarter of 2025, the Company entered into an agreement to finance certain annual insurance premiums for $9.4 million with a maturity date of June 1, 2026. The financing agreement has a fixed annual interest rate of 5.99% on the outstanding balance and requires monthly payments of principal and interest of $0.9 million.

The Company’s weighted average interest rate on all short-term debt outstanding, including the insurance premium financing and other short-term debt, for the quarter ended September 30, 2025, was 6.04%. Including the impact of interest rate swap agreements in effect as of September 30, 2025, the average rate is 5.90%.

Fair Value — At September 30, 2025, the aggregate fair value of the Company's total debt was $1,492.5 million and its carrying value was $1,505.6 million. At December 31, 2024, the aggregate fair value of the Company's total debt was $1,359.8 million and its carrying value was $1,405.0 million. The fair values of the Revolving Credit Facility, Term Loan A, and Term Loan A-1 were estimated using present value techniques and market-based interest rates and credit spreads. The insurance premium financing carrying value approximates fair value. The fair value of the Company's 2028 Notes was estimated based on quoted market prices for similar instruments due to their infrequent trading volume. Accordingly, the fair value of the Company's debt is classified as Level 2 within the valuation hierarchy.

Deferred Financing Costs — As of September 30, 2025 and December 31, 2024, deferred financing costs of $10.2 million and $6.7 million were included as a direct deduction from outstanding long-term debt, respectively. Fees associated with the Revolving Credit Facility are presented in Other assets, net. Deferred financing costs are amortized over their estimated useful lives based on the terms of their respective agreements.
v3.25.3
STOCKHOLDERS' EQUITY
 9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
STOCKHOLDERS' EQUITY
11. STOCKHOLDERS' EQUITY

Share Repurchase Authorization — On November 13, 2024, the Company announced that the Board of Directors (the "Board") authorized a $400 million stock repurchase program. This authorization is open ended, and any repurchases under the stock repurchase program may be made by means of open market transactions, negotiated block transactions, or otherwise, including pursuant to a repurchase plan administered in accordance with Rules 10b5-1 and 10b-18 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The size and timing of any repurchases will depend on price, market and business conditions, and other factors. The Company has the ability to make discretionary repurchases up to an annual cap of $150 million, and $393.5 million remained available under the $400 million total authorization of the stock repurchase program as of September 30, 2025. Any shares repurchased will be held as treasury stock.

The following table summarizes the Company's repurchases of its common stock:

Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
(In millions, except per share data)
Shares repurchased— — — 2.5 
Weighted average price per share$— $— $— $36.20 
Total cost$— $— $— $88.7 
Excise tax (1)$— $— $— $0.8 

(1)The excise tax accrued in connection with the share repurchases was recorded as an adjustment to the cost basis of repurchased shares in treasury stock and within Accrued expenses on the Company’s Condensed Consolidated Balance Sheets.
v3.25.3
EARNINGS PER SHARE
 9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
EARNINGS PER SHARE
12. EARNINGS PER SHARE

The weighted average number of common shares used in the diluted loss per share calculation is determined using the treasury stock method and includes the incremental effect related to the Company’s outstanding stock-based compensation awards. The following table summarizes the effect of the share-based compensation awards on the weighted average number of shares outstanding used in calculating diluted loss per share:
 
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
(In millions)
Weighted average common shares outstanding50.5 51.9 50.5 52.7 
Assumed exercise/vesting of equity awards (1)— — — — 
Weighted average diluted common shares outstanding50.5 51.9 50.5 52.7 
 
(1)For all periods presented, the weighted average common shares outstanding is the same for the computations of both basic and diluted shares outstanding because the Company had a net loss for the period. Equity awards, excluded from our computation of diluted earnings per share because they were anti-dilutive, were 1.3 million and 0.5 million for the three months ended September 30, 2025 and 2024, respectively, and 1.3 million and 0.6 million for the nine months ended September 30, 2025 and 2024, respectively.
v3.25.3
STOCK-BASED COMPENSATION
 9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION
13. STOCK-BASED COMPENSATION

The Board of Directors adopted, and the Company's stockholders approved, the "TreeHouse Foods, Inc. Equity and Incentive Plan" (the "Plan"). Under the Plan, the Compensation Committee may grant awards of various types of compensation, including stock options, restricted stock, restricted stock units, performance shares, performance units, other types of stock-based awards, and other cash-based compensation. The maximum number of shares authorized to be awarded under the Plan is approximately 22.5 million as of September 30, 2025.

Total compensation expense related to stock-based payments and the related income tax benefit recognized in Net loss are as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
(In millions)(In millions)
Compensation expense related to stock-based payments$4.8 $4.5 $15.2 $15.5 
Related income tax benefit1.2 1.1 3.6 3.7 
Stock Options — Stock options granted under the Plan during 2022 had a three-year vesting schedule, vested one-third on the second anniversary of the grant date and two-thirds on the third anniversary of the grant date, and expire ten years from the grant date. Stock options are generally only granted to employees and non-employee directors.

The following table summarizes stock option activity during 2025:
Employee
Options		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Term (yrs.)		Aggregate
Intrinsic
Value
(In thousands)(In millions)
Outstanding, at December 31, 2024473 $61.46 4.7$— 
Expired(62)78.67 
Outstanding, at September 30, 2025411 58.87 4.8— 
Exercisable, at September 30, 2025411 58.87 4.8— 
There are no future compensation costs related to unvested options at September 30, 2025.

Restricted Stock Units — Employee restricted stock unit awards generally vest based on the passage of time in approximately three equal installments on each of the first three anniversaries of the grant date.

Non-employee director restricted stock units generally vest on the first anniversary of the grant date. Certain non-employee directors have elected to defer receipt of their awards until either their departure from the Board of Directors or a specified date beyond the first anniversary of the grant date.

The following table summarizes the restricted stock unit activity during the nine months ended September 30, 2025:
 
Employee
Restricted
Stock Units		Weighted
Average
Grant Date
Fair Value
Non-Employee Director
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
 (In thousands) (In thousands) 
Nonvested, at December 31, 2024696 $38.82 62 $41.73 
Granted580 30.82 54 22.29 
Vested(315)38.15 (24)35.90 
Forfeited(196)35.15 — — 
Nonvested, at September 30, 2025765 33.97 92 31.84 
Earned and deferred, at September 30, 202538 45.41 
 
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
 (In millions)(In millions)
Fair value of vested restricted stock units$0.2 $0.4 $9.2 $10.2 
Tax benefit recognized from vested restricted stock units0.1 0.1 1.6 1.7 
 
Unrecognized compensation costs related to nonvested restricted stock units are approximately $19.9 million as of September 30, 2025 and will be recognized over a weighted average period of 1.9 years. The grant date fair value of the awards is equal to the Company's closing stock price on the grant date.
Performance Units — Performance unit awards, which are granted to certain members of management, contain service, performance, and market conditions as described below.

•For performance unit awards granted in 2022 through 2023, performance goals are set and measured annually with one-quarter of the units eligible to accrue for each year in the three-year performance period. Accrued shares are earned at the end of each performance period but remain subject to forfeiture until the third anniversary of the grant date.
•For performance unit awards granted in 2024 and 2025, performance goals were established upfront and will be measured over a cumulative three-year performance period. The units will accrue each month, multiplied by a predefined percentage between 0% and 200%, depending on the achievement of certain operating performance measures. Accrued shares are not earned until the end of the full three-year performance period and remain subject to forfeiture until the third anniversary of the grant date.

The performance unit awards include a tranche measured using a relative total shareholder return ("TSR") market condition over a three-year performance goal. The units will accrue, multiplied by a predefined percentage between 0% and 150% for years 2022 through 2023 and between 0% and 200% for 2024 and 2025, for the relative TSR measure, depending on the achievement attainment over the three-year performance period based on the Company's absolute annualized TSR relative to the annualized TSR of a Peer Group. These awards will be converted to stock or cash, at the discretion of the Compensation Committee, generally, on the third anniversary of the grant date. The Company intends to settle these awards in stock and has the shares available to do so.

Performance unit awards with market conditions are valued using a Monte Carlo simulation model. Expected volatility is based on the historical volatility of the Company’s stock price or the average Peer Group stock price. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of the grant with a term equivalent to the expected term of the award. The expected term is the time period from the grant date to the end of the performance period. The fair value of the portion of the awards based on relative TSR was valued using a Monte Carlo simulation model with a grant-date fair value of $38.26 on approximately 32,900 units granted in 2025. The assumptions used in the Monte Carlo simulation were as follows:

Nine Months Ended
September 30,
2025
Dividend yield0 %
Risk-free rate4.01 %
Expected volatility (TreeHouse Foods, Inc.)33.68 %
Expected volatility (Peer Group)36.45 %
Expected term (in years)2.84

The following table summarizes the performance unit activity during the nine months ended September 30, 2025:
Performance
Units		Weighted
Average
Grant Date
Fair Value
 (In thousands) 
Nonvested, at December 31, 2024378 $38.04 
Granted246 31.68 
Vested(92)33.14 
Forfeited(99)32.95 
Nonvested, at September 30, 2025433 35.18 
 
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
 (In millions)(In millions)
Fair value of vested performance units$— $— $2.4 $1.8 
Tax benefit recognized from performance units vested— — 0.1 0.1 

Unrecognized compensation costs related to nonvested performance units are estimated to be approximately $7.0 million as of September 30, 2025 and are expected to be recognized over a weighted average period of 1.8 years. The fair value of the portion of the awards granted based on market conditions were valued using a Monte Carlo simulation model. For other awards, the grant date fair value is equal to the Company's closing stock price on the date of grant.
v3.25.3
ACCUMULATED OTHER COMPREHENSIVE LOSS
 9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
ACCUMULATED OTHER COMPREHENSIVE LOSS
14. ACCUMULATED OTHER COMPREHENSIVE LOSS
 
Accumulated other comprehensive loss consists of the following components, all of which are net of tax:
 
Foreign
Currency
Translation (1)		Unrecognized
Pension and
Postretirement
Benefits (1)		Accumulated
Other
Comprehensive
Loss
 (In millions)
Balance at December 31, 2023$(84.2)$8.1 $(76.1)
Other comprehensive loss(2.4)— (2.4)
Balance at September 30, 2024$(86.6)$8.1 $(78.5)
Balance at December 31, 2024$(92.9)$10.2 $(82.7)
Other comprehensive income before reclassifications
3.1 — 3.1 
Reclassifications from accumulated other comprehensive loss (2)— (0.1)(0.1)
Other comprehensive income (loss)
3.1 (0.1)3.0 
Balance at September 30, 2025$(89.8)$10.1 $(79.7)
 
(1)The tax impact of the foreign currency translation adjustment and the unrecognized pension and postretirement benefits reclassification was insignificant for the three and nine months ended September 30, 2025 and 2024.
(2)Refer to Note 15 for additional information regarding these reclassifications.
v3.25.3
EMPLOYEE RETIREMENT AND POSTRETIREMENT BENEFITS
 9 Months Ended
Sep. 30, 2025
Retirement Benefits [Abstract]  
EMPLOYEE RETIREMENT AND POSTRETIREMENT BENEFITS
15. EMPLOYEE RETIREMENT AND POSTRETIREMENT BENEFITS

Pension, Profit Sharing, and Postretirement Benefits — Certain employees and retirees participate in pension and other postretirement benefit plans. Employee benefit plan obligations and expenses included in the Condensed Consolidated Financial Statements are determined based on plan assumptions, employee demographic data, including years of service and compensation, benefits and claims paid, and employer contributions.

Components of net periodic pension (benefit) cost are as follows:
 
Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
 (In millions)(In millions)
Service cost$0.1 $— $0.2 $0.2 
Interest cost2.6 2.5 8.0 7.7 
Expected return on plan assets(2.9)(2.7)(8.7)(8.1)
Amortization of unrecognized net loss0.1 0.1 0.2 0.3 
Net periodic pension (benefit) cost
$(0.1)$(0.1)$(0.3)$0.1 
Components of net periodic postretirement cost are as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
 (In millions)(In millions)
Interest cost$0.2 $0.2 $0.6 $0.6 
Amortization of unrecognized net gain(0.1)(0.1)(0.3)(0.3)
Net periodic postretirement cost$0.1 $0.1 $0.3 $0.3 

The service cost components of net periodic pension costs were recognized in Cost of sales, and the other components of net periodic pension and postretirement costs were recognized in Other (income) expense, net in the Condensed Consolidated Statements of Operations.

Subsequent Event - Annuity Lift-out
In October 2025, the Company completed a pension plan annuity lift-out, a transaction that provided for the purchase of an annuity contract to fund pension plan annuities of retirees, as part of our de-risking strategy. This annuity lift-out impacted approximately 800 retirees, as well as reduced $80.0 million in pension obligations and $74.0 million in plan assets which were transferred to an insurance company. The Company estimates a non-cash settlement gain on the annuity lift-out of $8.5 million will be recognized in the fourth quarter of 2025.
v3.25.3
COMMITMENTS AND CONTINGENCIES
 9 Months Ended
Sep. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
16. COMMITMENTS AND CONTINGENCIES

Griddle Product Recall Costs and Insurance Recovery

On October 18, 2024, the Company initiated a voluntary recall of certain frozen waffle products produced at its Brantford, Ontario, Canada facility, and on October 22, 2024, the Company expanded its voluntary recall to include all products manufactured at the Brantford facility that were still within their shelf-life. These frozen griddle products may have had the potential to be contaminated with Listeria monocytogenes. The Company recorded a product recall liability for estimated product returns and claims, which is included within Accrued expenses in the Condensed Consolidated Balance Sheets, of $14.5 million as of September 30, 2025 and $9.6 million as of December 31, 2024. The amount of the product recall liability represents the probable and reasonably estimable costs directly associated with the recall. However, the total actual costs could differ materially due to uncertainties related to customer return rates, additional recall expenses, litigation, or other unforeseen events.

During the third quarter of 2025, the Company recognized an additional $13.0 million insurance recovery for the voluntary griddle product recall in Cost of sales in the Condensed Consolidated Statements of Operations. As a result, the cumulative amount of insurance recoveries recognized for the nine months ended September 30, 2025 is $23.0 million. Subsequent to September 30, 2025, the Company was notified that it would be receiving an additional $7.0 million, resulting in a total amount of insurance recoveries received of $30.0 million. As of the fourth quarter of 2025, the Company expects to have received all potential insurance recoveries for griddle product recall-related costs through its insurance coverage.

Broth Product Recall Insurance Recovery

On September 22, 2023, the Company initiated a voluntary recall of certain broth products produced at its Cambridge, Maryland facility. These broth products may have had the potential for non-pathogenic microbial contamination due to lack of sterility assurance. During the third quarter of 2025, the Company recognized an additional $4.5 million insurance recovery in Cost of sales in the Condensed Consolidated Statements of Operations, resulting in $7.6 million of recoveries for the nine months ended September 30, 2025. The cumulative amount of insurance recoveries recognized to date for the broth product recall is $17.6 million. The Company is seeking to recover additional recall-related costs through its insurance coverage, and such recoveries are recorded in the period in which the recoveries are determined to be probable of realization.
Coffee Business Litigation

In February 2014, TreeHouse, along with its 100% owned subsidiaries, Bay Valley Foods, LLC and Sturm Foods, Inc., filed suit against Keurig Dr. Pepper Inc.'s wholly-owned subsidiary, Keurig Green Mountain ("KGM"), in the U.S. District Court for the Southern District of New York captioned TreeHouse Foods, Inc. et al. v. Green Mountain Coffee Roasters, Inc. et al. asserting claims under the federal antitrust laws, various state antitrust laws and unfair competition statutes, contending that KGM had monopolized alleged markets for single serve coffee brewers and single serve coffee pods. The Company is seeking monetary damages, declaratory relief, injunctive relief, and attorneys' fees, which monetary damages, in August 2020, were estimated by the Company's economic expert to be in the range of $719.4 million to $1.5 billion for the Company's antitrust claims, before trebling, and $358.0 million for a subset of the Company's false advertising claims, without accounting for discretionary trebling by the Court. The matter remains pending, with summary judgment motions fully briefed. On March 28, 2022, the Magistrate Judge issued an Opinion and Order granting in part and denying in part the TreeHouse sanctions motion against KGM and denying the KGM sanctions motion against TreeHouse. KGM has appealed a portion of the Opinion and Order awarding sanctions to the Company. On January 3, 2025, the Court denied KGM's motions to exclude the opinions of the Company's experts and granted Plaintiffs' motion to exclude the opinion of KGM's sham litigation expert. KGM is denying the allegations made by the Company in the litigation. The Company has not recorded any amount in its Condensed Consolidated Financial Statements as of September 30, 2025.

Other Claims

In addition, the Company is party in the ordinary course of business to certain claims, litigation, audits, and investigations. The Company will record an accrual for a loss contingency when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The Company believes it has established adequate accruals for liabilities that are probable and reasonably estimable that may be incurred in connection with any such currently pending or threatened matter. In the Company's opinion, the eventual resolution of such matters, either individually or in the aggregate, is not expected to have a material impact on the Company's financial position, results of operations, or cash flows. However, litigation is inherently unpredictable and resolutions or dispositions of claims or lawsuits by settlement or otherwise could have an adverse impact on our financial position, results of operations or cash flows for the reporting period in which any such resolution or disposition occurs.
v3.25.3
DERIVATIVE INSTRUMENTS
 9 Months Ended
Sep. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE INSTRUMENTS
17. DERIVATIVE INSTRUMENTS

Interest Rate Swap Agreements — The Company manages its exposure to changes in interest rates by optimizing the use of variable-rate and fixed-rate debt and by utilizing interest rate swaps to hedge our exposure to changes in interest rates, to reduce the volatility of our financing costs, and to achieve a desired proportion of fixed versus floating-rate debt, based on current and projected market conditions.

The Company has entered into long-term interest rate swap agreements to lock into a fixed interest rate base that have a notional value of $875.0 million as of September 30, 2025 and $1,750.0 million as of December 31, 2024. Under the terms of the agreements, $875.0 million in variable-rate debt is swapped for a weighted average fixed interest rate base of approximately 3.69% through February 29, 2028.

Commodity Contracts — Certain commodities the Company uses in the production and distribution of its products are exposed to market price risk. The Company utilizes derivative contracts to manage this risk. The majority of commodity forward contracts are not derivatives, and those that are generally qualify for the normal purchases and normal sales scope exception under the guidance for derivative instruments and hedging activities and, therefore, are not subject to its provisions. For derivative commodity contracts that do not qualify for the normal purchases and normal sales scope exception, the Company accounts for the contracts as derivatives.

The Company's derivative commodity contracts may include contracts for diesel, oil, plastics, resin, and other commodity contracts that do not meet the requirements for the normal purchases and normal sales scope exception. Diesel contracts are used to manage the Company's risk associated with the underlying cost of diesel fuel used to deliver products. Contracts for oil, plastics, and resin are used to manage the Company's risk associated with the underlying commodity cost of a significant component used in packaging materials. Other commodity contracts that are derivatives that do not meet the normal purchases and normal sales scope exception are used to manage the price risk associated with raw material costs. As of September 30, 2025 and December 31, 2024, the notional value of the commodity contracts outstanding was $91.0 million and $61.5 million, respectively. These commodity contracts have maturities expiring throughout 2025 and 2026 as of September 30, 2025.
 The following table identifies the fair value of each derivative instrument:
 Balance Sheet LocationSeptember 30, 2025December 31, 2024
(In millions)
Asset derivatives
Commodity contractsPrepaid expenses and other current assets$7.3 $9.1 
Interest rate swap agreementsPrepaid expenses and other current assets— 2.2 
Interest rate swap agreementsOther assets, net— 7.6 
 $7.3 $18.9 
Liability derivatives
Commodity contractsAccrued expenses$0.3 $— 
Interest rate swap agreementsAccrued expenses7.5 0.4 
 $7.8 $0.4 

The fair values of the commodity contracts and interest rate swap agreements are determined using Level 2 inputs. Level 2 inputs are inputs other than quoted market prices that are observable for an asset or liability, either directly or indirectly. The fair values of the commodity contracts and interest rate swap agreements are based on an analysis comparing the contract rates to the market rates at the balance sheet date.

We recognized the following gains and losses on our derivative contracts in the Condensed Consolidated Statements of Operations:
Location of Gain (Loss)
Three Months Ended
September 30,		Nine Months Ended
September 30,
 
Recognized in Net Income (Loss)
2025202420252024
  (In millions)(In millions)
Mark-to-market unrealized gain (loss)
    
Commodity contractsOther (income) expense, net$13.2 $6.5 $(2.1)$8.4 
Interest rate swap agreementsOther (income) expense, net(0.5)(26.0)(16.9)(19.4)
Total unrealized gain (loss)
 $12.7 $(19.5)$(19.0)$(11.0)
Realized (loss) gain
 
Commodity contracts
Manufacturing-related to Cost of sales and transportation-related to Selling and distribution
$(3.6)$0.8 $7.1 $4.6 
Interest rate swap agreementsInterest expense1.5 5.8 5.6 17.0 
Total realized (loss) gain
 $(2.1)$6.6 $12.7 $21.6 
Total gain (loss)
 $10.6 $(12.9)$(6.3)$10.6 
v3.25.3
SEGMENT INFORMATION
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
SEGMENT INFORMATION
18. SEGMENT INFORMATION

Segment Information —The Company has one reportable segment, which manufactures and distributes private brands food and beverages. Our products are primarily shelf stable and share similar customers and distribution. The Company derives revenue primarily in North America and manages the business activities on a consolidated basis. Those business activities include selling snacking offerings, beverages and drink mix offerings, and other grocery offerings across various channels including retail grocery, co-manufacturing, and food-away-from-home customers in shelf stable, refrigerated, and frozen formats. The majority of our manufacturing plants each produce one food or beverage category. We operate our business with a centralized financial systems infrastructure, and we share centralized resources for procurement and general and administrative activities. The accounting policies of the segment are the same as those described in the Summary of Significant Accounting Policies for the Company and can be found in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
The Chief Executive Officer ("CEO") has been identified as our Chief Operating Decision Maker ("CODM"). We have one segment manager who reports directly to the CODM, with their incentive compensation based on the consolidated results of the Company. The Company manages operations on a company-wide basis, thereby making determinations as to the allocation of resources as one segment. The annual operating plan is prepared and approved by the CODM based on consolidated results of the Company. The CODM uses discrete financial information at the consolidated level to assess performance for the segment and decides how to allocate resources based on the Company's consolidated Net loss, which is reported on the Condensed Consolidated Statements of Operations. The measure of segment assets is reported on the Condensed Consolidated Balance Sheets as Total assets.

Reported segment revenue, segment profit or loss, and significant segment expenses are as follows:

Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
(In millions)(In millions)
Net sales$840.3 $839.1 $2,430.3 $2,448.3 
Cost of sales682.4 707.9 2,018.0 2,076.8 
Selling, distribution, general, and administrative:
Freight out and commissions28.1 27.4 78.9 84.0 
Direct selling, general, and administrative14.7 8.8 49.3 28.6 
Corporate selling, general, and administrative39.3 45.8 132.3 157.8 
Amortization expense13.0 12.3 39.3 36.5 
Impairment289.7 — 289.7 19.3 
Other operating expense, net(1)27.2 5.1 55.1 22.7 
Total other expense(2)13.4 36.1 84.4 63.1 
Income tax benefit(1.7)(0.9)(16.2)(8.7)
Net loss$(265.8)$(3.4)$(300.5)$(31.8)

(1)Other operating expense, net includes other segment items, primarily including expenses related to Restructuring programs. Refer to Note 3 to our Condensed Consolidated Financial Statements for additional information.
(2)Total other expense includes other segment items, primarily including interest expense, interest income, loss on extinguishment of debt, foreign currency exchange, and mark-to-market adjustments on derivatives.

Disaggregation of Revenue — The principal products that comprise our different product category groups are as follows:

Product Category GroupPrincipal Products
SnackingCandy; cookies; crackers; in-store bakery items; pretzels; and frozen griddle items
Beverages & drink mixesBroths/stocks; non-dairy creamer; powdered beverages and other blends; ready-to-drink beverages (production ceased in the first quarter of 2025); coffee; and tea
GroceryCheese & pudding; hot cereal; pickles; and refrigerated dough
Revenue disaggregated by product category groups is as follows:

Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
 (In millions)(In millions)
Snacking$300.6 $318.2 $855.4 $941.9 
Beverages & drink mixes316.4 281.7 905.4 793.9 
Grocery223.3 239.2 669.5 712.5 
Total net sales$840.3 $839.1 $2,430.3 $2,448.3 
Revenue disaggregated by sales channel is as follows:

Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
 (In millions)(In millions)
Retail grocery$670.6 $674.2 $1,920.6 $1,931.6 
Co-manufacturing84.4 95.0 259.8 299.2 
Food-away-from-home and other85.3 69.9 249.9 217.5 
Total net sales$840.3 $839.1 $2,430.3 $2,448.3 
v3.25.3
SUBSEQUENT EVENT
 9 Months Ended
Sep. 30, 2025
Subsequent Events [Abstract]  
SUBSEQUENT EVENT SUBSEQUENT EVENT
On November 10, 2025, the Company, Industrial F&B Investments II, Inc., a Delaware corporation (“Investindustrial”), and Industrial F&B Investments III, Inc., a Delaware corporation and a wholly owned subsidiary of Investindustrial (“Merger Sub”), signed an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which Merger Sub would merge with and into TreeHouse, with TreeHouse continuing as the surviving corporation.
Under the terms of the agreement, TreeHouse Foods shareholders will receive $22.50 per share in cash for each share of common stock owned at closing, representing a total Enterprise Value of $2.9 billion, and one non-transferrable Contingent Value Right ("CVR") per common share. The CVR generally will provide a holder with an opportunity to receive certain net proceeds, if any are recovered, from certain ongoing litigation relating to part of TreeHouse Foods' coffee business. Refer to Note 16 to our Condensed Consolidated Financial Statements for additional information regarding the ongoing coffee business litigation.
The transaction is expected to close in the first quarter of 2026, subject to approval by TreeHouse Foods shareholders and satisfaction of regulatory approvals and other customary closing conditions. The transaction is not subject to a financing condition. Upon completion of the transaction, the Company's common stock will no longer be listed on the New York Stock Exchange, and TreeHouse Foods will become a private company.
v3.25.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.3
BASIS OF PRESENTATION (Policies)
 9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Use of Estimates
Use of Estimates

The preparation of our Condensed Consolidated Financial Statements in conformity with GAAP requires management to use judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements, and the reported amounts of net sales and expenses during the reporting period. Actual results could differ from these estimates.
Recent Accounting Pronouncements Not Yet Adopted
Not yet adopted

In September 2025, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. ASU 2025-06 modernizes the guidance for accounting for software costs by removing all references to software development project stages and clarifying criteria for capitalization. The amendment is effective for annual periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the provisions of the amendments and the effect on its future Consolidated Financial Statements.

In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. These amendments require disclosure of the election of a practical expedient that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset when estimating expected credit losses for current accounts receivable and current contract assets. The amendments are effective for annual periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. The Company is currently evaluating the provisions of the amendments and the effect on its future Consolidated Financial Statements.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, and in January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. ASU 2024-03 requires additional information about specific expenses in certain notes to the Consolidated Financial Statements. The new guidance in ASU 2024-03, as clarified by ASU 2025-01, will be effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. Upon adoption, the impact of ASU 2024-03 will be limited to certain notes to the Consolidated Financial Statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to enhance the transparency and decision usefulness of income tax disclosures. The amendments are effective for annual periods beginning after December 15, 2024 on a prospective basis. Early adoption is permitted. Upon adoption, the impact of ASU 2023-09 will be limited to certain notes to the Consolidated Financial Statements.
v3.25.3
RESTRUCTURING PROGRAMS (Tables)
 9 Months Ended
Sep. 30, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Aggregate Expenses Incurred Associated with Facility Closure
The costs by activity for the Restructuring Programs are outlined below:

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
(In millions)
Organizational restructuring$20.8 $3.1 $46.3 $16.9 
Facility closures13.23.721.68.1
Total$34.0 $6.8 $67.9 $25.0 
Below is a summary of costs by line item for the Restructuring Programs:

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
(In millions)
Cost of sales$6.7 $1.7 $12.4 $1.7 
Other operating expense, net27.3 5.1 55.5 23.3 
Total$34.0 $6.8 $67.9 $25.0 
Below is a summary of costs by type associated with organizational restructuring activities:

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
(In millions)
Asset-related$— $— $1.4 $— 
Employee-related10.4 0.2 19.2 7.5 
Other costs10.4 2.9 25.7 9.4 
Total$20.8 $3.1 $46.3 $16.9 
The key information regarding the Company’s announced facility closures is outlined in the table below.
Facility LocationDate Closure AnnouncedEnd of ProductionPrimary Products ProducedCumulative Costs to DateTotal Expected Costs
Chicago, IllinoisQ3 2025Expected Q4 2025Pickles$2.8 $6.0 
South Beloit, IllinoisQ3 2025Expected H1 2026Cookies4.3 14.0 
New Hampton, Iowa (1)Q1 2025Q3 2025Non-dairy creamer ("NDC")10.8 12.0 
Dallas, Texas (2)Q4 2023Q4 2023Single-serve beverage ("SSB") / Coffee13.7 14.0 
$31.6 $46.0 

(1)During the third quarter of 2025, the Company completed the sale of the New Hampton, Iowa facility for $7.9 million, and the Company consolidated its NDC production into two existing facilities: Wayland, Michigan, and Pecatonica, Illinois.
(2)During the fourth quarter of 2023, the Company completed the closure of its Dallas, Texas Coffee facility in connection with the integration of the Coffee Roasting Capability and transitioned production from Dallas to its Northlake, Texas facility during the first half of 2024. As the Company continued related integration activities, the Company exited a distribution center in Grand Prairie, Texas, during the third quarter of 2024. As a result of this distribution center exit, an impairment of $0.9 million of Operating lease right-of-use assets was recognized in our Grand Prairie asset group in the third quarter of 2024.
Below is a summary of costs by type associated with the facility closures:

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
(In millions)
Asset-related$4.9 $2.6 $9.4 $2.6 
Employee-related3.8 0.2 5.4 0.2 
Other costs4.5 0.9 6.8 5.3 
Total$13.2 $3.7 $21.6 $8.1 
Schedule of Activity of Restructuring Program Liabilities
The table below presents the exit cost liability related to severance activity for the Restructuring Programs as of September 30, 2025:
 Severance
 (In millions)
Balance as of December 31, 2024$1.8 
Expenses recognized19.5 
Cash payments(7.0)
Balance as of September 30, 2025$14.3 
v3.25.3
RECEIVABLES SALES PROGRAM (Tables)
 9 Months Ended
Sep. 30, 2025
Receivables [Abstract]  
Schedule of Receivable Sales Program
The following table includes the outstanding amount of accounts receivable sold under the Receivables Sales Program and the receivables collected from customers and not remitted to the financial institution that is included within outstanding accounts receivables sold:
September 30, 2025December 31, 2024
 (In millions)
Outstanding accounts receivable sold$221.7 $375.0 
Receivables collected and not remitted to financial institution181.1 237.7 
The following table summarizes the cash flows of the Company's accounts receivable associated with the Receivables Sales Program:
Nine Months Ended September 30,
20252024
 (In millions)
Receivables sold$855.3 $891.6 
Receivables collected and remitted to financial institution(1,008.6)(993.9)
v3.25.3
INVENTORIES (Tables)
 9 Months Ended
Sep. 30, 2025
Inventory Disclosure [Abstract]  
Schedule of Inventories
September 30, 2025December 31, 2024
 (In millions)
Raw materials and supplies$222.7 $217.4 
Finished goods445.5 321.9 
Total inventories$668.2 $539.3 
v3.25.3
ACQUISITIONS (Tables)
 9 Months Ended
Sep. 30, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Schedule of Business Acquisitions Consideration
The following table summarizes the preliminary purchase price allocation of the fair value of net tangible and intangible assets acquired and liabilities assumed:
(In millions)
Cash transferred at close
$209.6 
Preliminary purchase price adjustment
(2.0)
Total consideration transferred$207.6 
Allocation of consideration to assets acquired and liabilities assumed:
Cash
$0.3 
Receivables
11.4 
Inventories41.8 
Property, plant, and equipment
19.0 
Operating lease right-of-use assets
25.7 
Goodwill69.7 
Customer relationships65.0 
Trademarks
12.9 
Other assets0.6 
Assets acquired246.4 
Assumed liabilities(38.8)
Total purchase price$207.6 
The following table summarizes the purchase price allocation of the fair value of net tangible and intangible assets acquired:

(In millions)
Cash transferred at close$20.0 
Purchase price adjustment5.9 
Total consideration transferred$25.9 
Allocation of consideration to assets acquired:
Inventories$25.2 
Trademarks0.7 
Total purchase price$25.9 
Schedule of Preliminary Purchase Price Allocation of Fair value of Net Tangible Assets Acquired
The following table summarizes the preliminary purchase price allocation of the fair value of net tangible and intangible assets acquired and liabilities assumed:
(In millions)
Cash transferred at close
$209.6 
Preliminary purchase price adjustment
(2.0)
Total consideration transferred$207.6 
Allocation of consideration to assets acquired and liabilities assumed:
Cash
$0.3 
Receivables
11.4 
Inventories41.8 
Property, plant, and equipment
19.0 
Operating lease right-of-use assets
25.7 
Goodwill69.7 
Customer relationships65.0 
Trademarks
12.9 
Other assets0.6 
Assets acquired246.4 
Assumed liabilities(38.8)
Total purchase price$207.6 
The following table summarizes the purchase price allocation of the fair value of net tangible and intangible assets acquired:

(In millions)
Cash transferred at close$20.0 
Purchase price adjustment5.9 
Total consideration transferred$25.9 
Allocation of consideration to assets acquired:
Inventories$25.2 
Trademarks0.7 
Total purchase price$25.9 
Schedule of Pro Forma Information
The following unaudited pro forma information shows the results of operations for the Company as if its Harris Tea acquisition had been completed as of January 1, 2024. Adjustments have been made for the pro forma effects of depreciation and amortization of tangible and intangible assets recognized as part of the business combination, the amortization of the inventory fair value step-up, the amortization of off-market lease adjustments, acquisition-related costs, and related income taxes. The pro forma results may not necessarily reflect actual results of operations that would have been achieved, nor are they necessarily indicative of future results of operations.

Three Months Ended September 30, 2024Nine Months Ended September 30, 2024
(Unaudited, in millions)
Pro forma net sales
$874.7 $2,554.6 
Pro forma net income (loss)— (28.1)
v3.25.3
PROPERTY, PLANT, AND EQUIPMENT (Tables)
 9 Months Ended
Sep. 30, 2025
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant, and Equipment
September 30, 2025December 31, 2024
(In millions)
Land$35.7 $35.0 
Buildings and improvements375.7 378.1 
Machinery and equipment1,092.0 1,063.3 
Construction in progress123.0 120.6 
Total1,626.4 1,597.0 
Less accumulated depreciation(881.6)(848.4)
Property, plant, and equipment, net$744.8 $748.6 
v3.25.3
GOODWILL AND INTANGIBLE ASSETS (Tables)
 9 Months Ended
Sep. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in Carrying Amount of Goodwill
Goodwill
 (In millions)
Balance at December 31, 2024$1,819.3 
Foreign currency exchange adjustments2.1 
Acquisition69.7 
Impairment loss(289.7)
Balance at September 30, 2025$1,601.4 
Schedule of Gross Carrying Amounts and Accumulated Amortization of Intangible Assets, with Finite Lives
The gross carrying amounts and accumulated amortization of intangible assets as of September 30, 2025 and December 31, 2024 are as follows:

 September 30, 2025December 31, 2024
Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount
 (In millions)
Intangible assets with finite lives:      
Customer-related$612.2 $(424.3)$187.9 $546.0 $(395.6)$150.4 
Trademarks31.3 (18.0)13.3 19.2 (17.0)2.2 
Formulas/recipes15.4 (15.2)0.2 15.4 (15.0)0.4 
Computer software190.6 (143.7)46.9 212.6 (158.7)53.9 
Total finite lived intangibles849.5 (601.2)248.3 793.2 (586.3)206.9 
Intangible assets with indefinite lives:
Trademarks6.0 — 6.0 6.0 — 6.0 
Total intangible assets$855.5 $(601.2)$254.3 $799.2 $(586.3)$212.9 
Schedule of Gross Carrying Amounts of Intangible Assets, with Indefinite Lives
The gross carrying amounts and accumulated amortization of intangible assets as of September 30, 2025 and December 31, 2024 are as follows:

 September 30, 2025December 31, 2024
Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount
 (In millions)
Intangible assets with finite lives:      
Customer-related$612.2 $(424.3)$187.9 $546.0 $(395.6)$150.4 
Trademarks31.3 (18.0)13.3 19.2 (17.0)2.2 
Formulas/recipes15.4 (15.2)0.2 15.4 (15.0)0.4 
Computer software190.6 (143.7)46.9 212.6 (158.7)53.9 
Total finite lived intangibles849.5 (601.2)248.3 793.2 (586.3)206.9 
Intangible assets with indefinite lives:
Trademarks6.0 — 6.0 6.0 — 6.0 
Total intangible assets$855.5 $(601.2)$254.3 $799.2 $(586.3)$212.9 
v3.25.3
DEBT (Tables)
 9 Months Ended
Sep. 30, 2025
Debt Disclosure [Abstract]  
Schedule of Long-Term Debt
September 30, 2025December 31, 2024
 (In millions)
Revolving Credit Facility$95.0 $— 
Term Loan A480.0 316.4 
Term Loan A-1422.9 588.6 
2028 Notes500.0 500.0 
Insurance premium financing7.7 — 
Finance leases4.1 4.1 
Total outstanding debt1,509.7 1,409.1 
Deferred financing costs(10.2)(6.7)
Less current portion(13.4)(1.1)
Total long-term debt$1,486.1 $1,401.3 
Schedule of Maturities of Long-Term Debt
The scheduled maturities of outstanding debt, excluding deferred financing costs, at September 30, 2025 are as follows (in millions):

Remainder of 2025$4.0
202610.7
202718.1
2028522.2
202921.6
Thereafter933.1
     Total outstanding debt$1,509.7
v3.25.3
STOCKHOLDERS' EQUITY (Tables)
 9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of Repurchases of Common Stock
The following table summarizes the Company's repurchases of its common stock:

Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
(In millions, except per share data)
Shares repurchased— — — 2.5 
Weighted average price per share$— $— $— $36.20 
Total cost$— $— $— $88.7 
Excise tax (1)$— $— $— $0.8 

(1)The excise tax accrued in connection with the share repurchases was recorded as an adjustment to the cost basis of repurchased shares in treasury stock and within Accrued expenses on the Company’s Condensed Consolidated Balance Sheets.
v3.25.3
EARNINGS PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Effect of Share-Based Compensation Awards on Weighted Average Number of Shares Outstanding Used in Calculating Diluted Earnings (Loss) Per Share The following table summarizes the effect of the share-based compensation awards on the weighted average number of shares outstanding used in calculating diluted loss per share:
 
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
(In millions)
Weighted average common shares outstanding50.5 51.9 50.5 52.7 
Assumed exercise/vesting of equity awards (1)— — — — 
Weighted average diluted common shares outstanding50.5 51.9 50.5 52.7 
 
(1)For all periods presented, the weighted average common shares outstanding is the same for the computations of both basic and diluted shares outstanding because the Company had a net loss for the period. Equity awards, excluded from our computation of diluted earnings per share because they were anti-dilutive, were 1.3 million and 0.5 million for the three months ended September 30, 2025 and 2024, respectively, and 1.3 million and 0.6 million for the nine months ended September 30, 2025 and 2024, respectively.
v3.25.3
STOCK-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Total Compensation Expense
Total compensation expense related to stock-based payments and the related income tax benefit recognized in Net loss are as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
(In millions)(In millions)
Compensation expense related to stock-based payments$4.8 $4.5 $15.2 $15.5 
Related income tax benefit1.2 1.1 3.6 3.7 
Schedule of Stock Option Activity
The following table summarizes stock option activity during 2025:
Employee
Options		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Term (yrs.)		Aggregate
Intrinsic
Value
(In thousands)(In millions)
Outstanding, at December 31, 2024473 $61.46 4.7$— 
Expired(62)78.67 
Outstanding, at September 30, 2025411 58.87 4.8— 
Exercisable, at September 30, 2025411 58.87 4.8— 
Schedule of Restricted Stock Unit Activity
The following table summarizes the restricted stock unit activity during the nine months ended September 30, 2025:
 
Employee
Restricted
Stock Units		Weighted
Average
Grant Date
Fair Value
Non-Employee Director
Restricted
Stock Units
Weighted
Average
Grant Date
Fair Value
 (In thousands) (In thousands) 
Nonvested, at December 31, 2024696 $38.82 62 $41.73 
Granted580 30.82 54 22.29 
Vested(315)38.15 (24)35.90 
Forfeited(196)35.15 — — 
Nonvested, at September 30, 2025765 33.97 92 31.84 
Earned and deferred, at September 30, 202538 45.41 
Schedule of Highlight of Restricted Stock Unit Activity
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
 (In millions)(In millions)
Fair value of vested restricted stock units$0.2 $0.4 $9.2 $10.2 
Tax benefit recognized from vested restricted stock units0.1 0.1 1.6 1.7 
Schedule of Assumptions Used in the Monte Carlo Simulation The assumptions used in the Monte Carlo simulation were as follows:
Nine Months Ended
September 30,
2025
Dividend yield0 %
Risk-free rate4.01 %
Expected volatility (TreeHouse Foods, Inc.)33.68 %
Expected volatility (Peer Group)36.45 %
Expected term (in years)2.84
Schedule of Performance Unit Activity
The following table summarizes the performance unit activity during the nine months ended September 30, 2025:
Performance
Units		Weighted
Average
Grant Date
Fair Value
 (In thousands) 
Nonvested, at December 31, 2024378 $38.04 
Granted246 31.68 
Vested(92)33.14 
Forfeited(99)32.95 
Nonvested, at September 30, 2025433 35.18 
Schedule of Highlight of Performance Unit Activity
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
 (In millions)(In millions)
Fair value of vested performance units$— $— $2.4 $1.8 
Tax benefit recognized from performance units vested— — 0.1 0.1 
v3.25.3
ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)
 9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of Components of Accumulated Other Comprehensive Loss Net of Tax
Accumulated other comprehensive loss consists of the following components, all of which are net of tax:
 
Foreign
Currency
Translation (1)		Unrecognized
Pension and
Postretirement
Benefits (1)		Accumulated
Other
Comprehensive
Loss
 (In millions)
Balance at December 31, 2023$(84.2)$8.1 $(76.1)
Other comprehensive loss(2.4)— (2.4)
Balance at September 30, 2024$(86.6)$8.1 $(78.5)
Balance at December 31, 2024$(92.9)$10.2 $(82.7)
Other comprehensive income before reclassifications
3.1 — 3.1 
Reclassifications from accumulated other comprehensive loss (2)— (0.1)(0.1)
Other comprehensive income (loss)
3.1 (0.1)3.0 
Balance at September 30, 2025$(89.8)$10.1 $(79.7)
 
(1)The tax impact of the foreign currency translation adjustment and the unrecognized pension and postretirement benefits reclassification was insignificant for the three and nine months ended September 30, 2025 and 2024.
(2)Refer to Note 15 for additional information regarding these reclassifications.
v3.25.3
EMPLOYEE RETIREMENT AND POSTRETIREMENT BENEFITS (Tables)
 9 Months Ended
Sep. 30, 2025
Retirement Benefits [Abstract]  
Schedule of Net Periodic Pension (Benefit) Cost and Postretirement Cost
Components of net periodic pension (benefit) cost are as follows:
 
Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
 (In millions)(In millions)
Service cost$0.1 $— $0.2 $0.2 
Interest cost2.6 2.5 8.0 7.7 
Expected return on plan assets(2.9)(2.7)(8.7)(8.1)
Amortization of unrecognized net loss0.1 0.1 0.2 0.3 
Net periodic pension (benefit) cost
$(0.1)$(0.1)$(0.3)$0.1 
Components of net periodic postretirement cost are as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
 (In millions)(In millions)
Interest cost$0.2 $0.2 $0.6 $0.6 
Amortization of unrecognized net gain(0.1)(0.1)(0.3)(0.3)
Net periodic postretirement cost$0.1 $0.1 $0.3 $0.3 
v3.25.3
DERIVATIVE INSTRUMENTS (Tables)
 9 Months Ended
Sep. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Fair Value of Derivative Instrument The following table identifies the fair value of each derivative instrument:
 Balance Sheet LocationSeptember 30, 2025December 31, 2024
(In millions)
Asset derivatives
Commodity contractsPrepaid expenses and other current assets$7.3 $9.1 
Interest rate swap agreementsPrepaid expenses and other current assets— 2.2 
Interest rate swap agreementsOther assets, net— 7.6 
 $7.3 $18.9 
Liability derivatives
Commodity contractsAccrued expenses$0.3 $— 
Interest rate swap agreementsAccrued expenses7.5 0.4 
 $7.8 $0.4 
Schedule of Gains and Losses on Derivative Contracts
We recognized the following gains and losses on our derivative contracts in the Condensed Consolidated Statements of Operations:
Location of Gain (Loss)
Three Months Ended
September 30,		Nine Months Ended
September 30,
 
Recognized in Net Income (Loss)
2025202420252024
  (In millions)(In millions)
Mark-to-market unrealized gain (loss)
    
Commodity contractsOther (income) expense, net$13.2 $6.5 $(2.1)$8.4 
Interest rate swap agreementsOther (income) expense, net(0.5)(26.0)(16.9)(19.4)
Total unrealized gain (loss)
 $12.7 $(19.5)$(19.0)$(11.0)
Realized (loss) gain
 
Commodity contracts
Manufacturing-related to Cost of sales and transportation-related to Selling and distribution
$(3.6)$0.8 $7.1 $4.6 
Interest rate swap agreementsInterest expense1.5 5.8 5.6 17.0 
Total realized (loss) gain
 $(2.1)$6.6 $12.7 $21.6 
Total gain (loss)
 $10.6 $(12.9)$(6.3)$10.6 
v3.25.3
SEGMENT INFORMATION (Tables)
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Reported Segment Revenue, Profit or Loss and Significant Segment Expenses
Reported segment revenue, segment profit or loss, and significant segment expenses are as follows:

Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
(In millions)(In millions)
Net sales$840.3 $839.1 $2,430.3 $2,448.3 
Cost of sales682.4 707.9 2,018.0 2,076.8 
Selling, distribution, general, and administrative:
Freight out and commissions28.1 27.4 78.9 84.0 
Direct selling, general, and administrative14.7 8.8 49.3 28.6 
Corporate selling, general, and administrative39.3 45.8 132.3 157.8 
Amortization expense13.0 12.3 39.3 36.5 
Impairment289.7 — 289.7 19.3 
Other operating expense, net(1)27.2 5.1 55.1 22.7 
Total other expense(2)13.4 36.1 84.4 63.1 
Income tax benefit(1.7)(0.9)(16.2)(8.7)
Net loss$(265.8)$(3.4)$(300.5)$(31.8)

(1)Other operating expense, net includes other segment items, primarily including expenses related to Restructuring programs. Refer to Note 3 to our Condensed Consolidated Financial Statements for additional information.
(2)Total other expense includes other segment items, primarily including interest expense, interest income, loss on extinguishment of debt, foreign currency exchange, and mark-to-market adjustments on derivatives.
Schedule of Segment Revenue Disaggregated by Product Category and Sales Channel
Revenue disaggregated by product category groups is as follows:

Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
 (In millions)(In millions)
Snacking$300.6 $318.2 $855.4 $941.9 
Beverages & drink mixes316.4 281.7 905.4 793.9 
Grocery223.3 239.2 669.5 712.5 
Total net sales$840.3 $839.1 $2,430.3 $2,448.3 
Revenue disaggregated by sales channel is as follows:

Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
 (In millions)(In millions)
Retail grocery$670.6 $674.2 $1,920.6 $1,931.6 
Co-manufacturing84.4 95.0 259.8 299.2 
Food-away-from-home and other85.3 69.9 249.9 217.5 
Total net sales$840.3 $839.1 $2,430.3 $2,448.3 
v3.25.3
RESTRUCTURING PROGRAMS - Schedule of Aggregate Expenses Incurred Associated with Facility Closure (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ 34.0 $ 6.8 $ 67.9 $ 25.0
Cost of sales        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 6.7 1.7 12.4 1.7
Other operating expense, net        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 27.3 5.1 55.5 23.3
Organizational restructuring        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 20.8 3.1 46.3 16.9
Organizational restructuring | Asset-related        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 0.0 0.0 1.4 0.0
Organizational restructuring | Employee-related        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 10.4 0.2 19.2 7.5
Organizational restructuring | Other costs        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 10.4 2.9 25.7 9.4
Facility closures        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 13.2 3.7 21.6 8.1
Facility closures | Asset-related        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 4.9 2.6 9.4 2.6
Facility closures | Employee-related        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 3.8 0.2 5.4 0.2
Facility closures | Other costs        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ 4.5 $ 0.9 $ 6.8 $ 5.3
v3.25.3
RESTRUCTURING PROGRAMS - Schedule of Activity of Restructuring Program Liabilities (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Restructuring Reserve [Roll Forward]        
Expenses recognized $ 34.0 $ 6.8 $ 67.9 $ 25.0
Employee Severance        
Restructuring Reserve [Roll Forward]        
Beginning Balance     1.8  
Expenses recognized     19.5  
Cash payments     (7.0)  
Ending Balance $ 14.3   $ 14.3  
v3.25.3
RESTRUCTURING PROGRAMS - Schedule of Facility Closures (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Restructuring Cost and Reserve [Line Items]        
Cumulative Costs to Date $ 31.6   $ 31.6  
Total Expected Costs 46.0   46.0  
Proceeds from sales of fixed assets     12.7 $ 1.4
Facility closures        
Restructuring Cost and Reserve [Line Items]        
Operating lease right-of-use assets impairment loss   $ 0.9    
Chicago, Illinois | Facility closures        
Restructuring Cost and Reserve [Line Items]        
Cumulative Costs to Date 2.8   2.8  
Total Expected Costs 6.0   6.0  
South Beloit, Illinois | Facility closures        
Restructuring Cost and Reserve [Line Items]        
Cumulative Costs to Date 4.3   4.3  
Total Expected Costs 14.0   14.0  
New Hampton, Iowa | Facility closures        
Restructuring Cost and Reserve [Line Items]        
Cumulative Costs to Date 10.8   10.8  
Total Expected Costs 12.0   12.0  
Proceeds from sales of fixed assets 7.9      
Dallas, Texas | Facility closures        
Restructuring Cost and Reserve [Line Items]        
Cumulative Costs to Date 13.7   13.7  
Total Expected Costs $ 14.0   $ 14.0  
v3.25.3
RESTRUCTURING PROGRAMS - Additional Information (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Restructuring Cost and Reserve [Line Items]        
Expected cost $ 46.0   $ 46.0  
Restructuring costs incurred 31.6   31.6  
Restructuring charges 34.0 $ 6.8 67.9 $ 25.0
Ready-To-Drink Business Exit        
Restructuring Cost and Reserve [Line Items]        
Expected cost 4.0   4.0  
Restructuring costs incurred 3.9   3.9  
Restructuring charges $ 0.5   $ 2.0  
v3.25.3
RECEIVABLES SALES PROGRAM - Additional Information (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Receivables [Abstract]        
Termination period     60 days  
Receivables held for sale $ 397.5   $ 397.5  
Loss on sale of receivables $ 1.5 $ 2.7 $ 5.7 $ 6.6
v3.25.3
RECEIVABLES SALES PROGRAM - Accounts Receivable Sold the Receivable Sales Program (Details) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Receivables [Abstract]      
Outstanding accounts receivable sold $ 221.7   $ 375.0
Receivables collected and not remitted to financial institution 181.1   $ 237.7
Receivables sold 855.3 $ 891.6  
Receivables collected and remitted to financial institution $ (1,008.6) $ (993.9)  
v3.25.3
INVENTORIES (Details) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Inventory Disclosure [Abstract]    
Raw materials and supplies $ 222.7 $ 217.4
Finished goods 445.5 321.9
Total inventories $ 668.2 $ 539.3
v3.25.3
ACQUISITIONS - Additional Information (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Jan. 02, 2025
Jan. 02, 2024
Sep. 30, 2025
Sep. 30, 2025
Dec. 31, 2024
Business Combination [Line Items]          
Goodwill     $ 1,601.4 $ 1,601.4 $ 1,819.3
Harris Tea          
Business Combination [Line Items]          
Purchase price $ 207.6        
Net sales of acquiree since acquisition date       110.6  
Income before income taxes of acquiree since acquisition date       8.1  
Acquisition related costs 3.4   $ 0.2 $ 0.7  
Receivables 11.4        
Operating lease right-of-use assets 25.7        
Off-market fair value adjustment 6.5        
Increase in cost of acquired inventories 1.9        
Goodwill 69.7        
Harris Tea | Customer relationships          
Business Combination [Line Items]          
Finite-lived intangible assets $ 65.0        
Estimated useful life of trademarks 20 years        
Harris Tea | Trademarks          
Business Combination [Line Items]          
Finite-lived intangible assets $ 12.9        
Estimated useful life of trademarks 10 years        
Pickle Branded Assets          
Business Combination [Line Items]          
Purchase price   $ 25.9      
Pickle Branded Assets | Trademarks          
Business Combination [Line Items]          
Finite-lived intangible assets   $ 0.7      
Estimated useful life of trademarks   10 years      
v3.25.3
ACQUISITIONS - Preliminary Purchase Price Allocation of Fair Value of Net Tangible Assets Acquired (Details) - USD ($)
$ in Millions
Jan. 02, 2025
Jan. 02, 2024
Sep. 30, 2025
Dec. 31, 2024
Allocation of consideration to assets acquired:        
Goodwill     $ 1,601.4 $ 1,819.3
Harris Tea        
Business Combination [Line Items]        
Cash transferred at close $ 209.6      
Preliminary purchase price adjustment (2.0)      
Total consideration transferred 207.6      
Allocation of consideration to assets acquired:        
Cash 0.3      
Receivables 11.4      
Inventories 41.8      
Property, plant, and equipment 19.0      
Operating lease right-of-use assets 25.7      
Goodwill 69.7      
Other assets 0.6      
Assets acquired 246.4      
Assumed liabilities (38.8)      
Total purchase price 207.6      
Harris Tea | Customer relationships        
Allocation of consideration to assets acquired:        
Finite-lived intangible assets 65.0      
Harris Tea | Trademarks        
Allocation of consideration to assets acquired:        
Finite-lived intangible assets $ 12.9      
Pickle Branded Assets        
Business Combination [Line Items]        
Cash transferred at close   $ 20.0    
Preliminary purchase price adjustment   5.9    
Total consideration transferred   25.9    
Allocation of consideration to assets acquired:        
Inventories   25.2    
Total purchase price   25.9    
Pickle Branded Assets | Trademarks        
Allocation of consideration to assets acquired:        
Finite-lived intangible assets   $ 0.7    
v3.25.3
ACQUISITIONS - Pro Forma Information (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2024
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]    
Pro forma net sales $ 874.7 $ 2,554.6
Pro forma net income (loss) $ 0.0 $ (28.1)
v3.25.3
PROPERTY, PLANT, AND EQUIPMENT - Components (Details) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 1,626.4 $ 1,597.0
Less accumulated depreciation (881.6) (848.4)
Property, plant, and equipment, net 744.8 748.6
Land    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 35.7 35.0
Buildings and improvements    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 375.7 378.1
Machinery and equipment    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 1,092.0 1,063.3
Construction in progress    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 123.0 $ 120.6
v3.25.3
PROPERTY, PLANT, AND EQUIPMENT - Additional Information (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Property, Plant and Equipment [Abstract]          
Depreciation expense $ 28.7 $ 24.4   $ 85.9 $ 73.0
Impairment $ 289.7 $ 0.0 $ 19.3 $ 289.7 $ 19.3
v3.25.3
GOODWILL AND INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2025
Goodwill [Roll Forward]    
Beginning Balance   $ 1,819.3
Foreign currency exchange adjustments   2.1
Acquisition   69.7
Impairment loss $ (289.7) (289.7)
Ending Balance $ 1,601.4 $ 1,601.4
v3.25.3
GOODWILL AND INTANGIBLE ASSETS - Additional Information (Details)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
Sep. 30, 2025
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]    
Non-cash goodwill, Impairment Loss $ 289.7 $ 289.7
Accumulated goodwill impairment losses $ 289.7 $ 289.7
v3.25.3
GOODWILL AND INTANGIBLE ASSETS - Gross Carrying Amounts and Accumulated Amortization of Intangible Assets, with Finite Lives (Details) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 849.5 $ 793.2
Accumulated Amortization (601.2) (586.3)
Net Carrying Amount 248.3 206.9
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Gross Carrying Amount 855.5 799.2
Accumulated Amortization (601.2) (586.3)
Intangible assets, net 254.3 212.9
Trademarks    
Indefinite-lived Intangible Assets [Line Items]    
Intangible assets with indefinite lives: 6.0 6.0
Customer-related    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 612.2 546.0
Accumulated Amortization (424.3) (395.6)
Net Carrying Amount 187.9 150.4
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization (424.3) (395.6)
Trademarks    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 31.3 19.2
Accumulated Amortization (18.0) (17.0)
Net Carrying Amount 13.3 2.2
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization (18.0) (17.0)
Formulas/recipes    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 15.4 15.4
Accumulated Amortization (15.2) (15.0)
Net Carrying Amount 0.2 0.4
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization (15.2) (15.0)
Computer software    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 190.6 212.6
Accumulated Amortization (143.7) (158.7)
Net Carrying Amount 46.9 53.9
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
Accumulated Amortization $ (143.7) $ (158.7)
v3.25.3
INCOME TAXES (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Tax Disclosure [Abstract]        
Effective income tax rate 0.60% 20.90% 5.10% 21.50%
Decrease in unrecognized tax benefits is reasonably possible $ 0.4   $ 0.4  
v3.25.3
DEBT (Details) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Debt Instrument [Line Items]    
Finance leases $ 4.1 $ 4.1
Total outstanding debt 1,509.7 1,409.1
Deferred financing costs (10.2) (6.7)
Less current portion (13.4) (1.1)
Total long-term debt 1,486.1 1,401.3
2028 Notes    
Debt Instrument [Line Items]    
2028 Notes 500.0 500.0
Insurance premium financing    
Debt Instrument [Line Items]    
Insurance premium financing 7.7 0.0
Revolving Credit Facility    
Debt Instrument [Line Items]    
Revolving Credit Facility 95.0 0.0
Term Loan A    
Debt Instrument [Line Items]    
Term loan 480.0 316.4
Term Loan A-1    
Debt Instrument [Line Items]    
Term loan $ 422.9 $ 588.6
v3.25.3
DEBT- Scheduled Maturities of Outstanding Debt, Excluding Deferred Financing Costs (Details) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Debt Disclosure [Abstract]    
Remainder of 2025 $ 4.0  
2026 10.7  
2027 18.1  
2028 522.2  
2029 21.6  
Thereafter 933.1  
Total outstanding debt $ 1,509.7 $ 1,409.1
v3.25.3
DEBT - Additional Information (Details) - USD ($)
 3 Months Ended 9 Months Ended
Jan. 17, 2025
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Sep. 09, 2020
Dec. 01, 2017
Debt Instrument [Line Items]                  
Loss on extinguishment of debt   $ 0   $ 0 $ 2,600,000 $ 0      
Amount drawn on line of credit         2,251,900,000 $ 212,500,000      
Long-term debt, fair value   1,492,500,000     1,492,500,000   $ 1,359,800,000    
Long-term debt, carrying value   1,505,600,000     1,505,600,000   1,405,000,000    
Deferred financing costs   $ 10,200,000     $ 10,200,000   $ 6,700,000    
Unsecured Debt                  
Debt Instrument [Line Items]                  
Weighted average interest rate   6.04%     6.04%        
Interest rate swap agreements | Unsecured Debt                  
Debt Instrument [Line Items]                  
Weighted average interest rate   5.90%     5.90%        
2028 Notes                  
Debt Instrument [Line Items]                  
Aggregate principal amount               $ 500,000,000  
Stated interest rate               4.00%  
Insurance premium financing | Unsecured Debt                  
Debt Instrument [Line Items]                  
Aggregate principal amount   $ 9,400,000     $ 9,400,000        
Stated interest rate   5.99%     5.99%        
Debt instrument, periodic payment   $ 900,000              
Revolving Credit Facility                  
Debt Instrument [Line Items]                  
Revolving credit facility, maximum borrowing capacity $ 500,000,000               $ 500,000,000
Loss on extinguishment of debt     $ 2,600,000            
Amount drawn on line of credit         $ 95,000,000        
Revolving credit facility available   372,200,000     372,200,000        
Letters of credit facility issued but undrawn   $ 32,800,000     $ 32,800,000        
Commitment fee percentage 0.30%                
Net leverage ratio 4.50                
Cross default triggering amount $ 75,000,000                
Revolving Credit Facility | Minimum                  
Debt Instrument [Line Items]                  
Commitment fee percentage 0.20%                
Revolving Credit Facility | Maximum                  
Debt Instrument [Line Items]                  
Commitment fee percentage 0.40%                
Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Minimum                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 1.25%                
Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Maximum                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 2.50%                
Revolving Credit Facility | Base Rate | Minimum                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 0.25%                
Revolving Credit Facility | Base Rate | Maximum                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 1.50%                
Term Loan A                  
Debt Instrument [Line Items]                  
Aggregate principal amount $ 480,000,000               500,000,000
Term Loan A | Secured Overnight Financing Rate (SOFR) | Minimum                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 1.525%                
Term Loan A | Secured Overnight Financing Rate (SOFR) | Maximum                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 2.775%                
Term Loan A | Base Rate | Minimum                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 0.525%                
Term Loan A | Base Rate | Maximum                  
Debt Instrument [Line Items]                  
Basis spread on variable rate 1.775%                
Term Loan A-1                  
Debt Instrument [Line Items]                  
Aggregate principal amount $ 425,000,000               $ 900,000,000
Term Loan A-1 | Debt Covenant Period One                  
Debt Instrument [Line Items]                  
Quarterly payment, percentage of original commitment 0.25%                
Term Loan A-1 | Debt Covenant Period Two                  
Debt Instrument [Line Items]                  
Quarterly payment, percentage of original commitment 1.25%                
v3.25.3
STOCKHOLDERS' EQUITY - Additional Information (Details) - Common Stock - USD ($)
Sep. 30, 2025
Nov. 13, 2024
Nov. 02, 2017
Equity, Class of Treasury Stock [Line Items]      
Stock repurchase program, expected annual cap     $ 150,000,000
Remaining authorized repurchase amount $ 393,500,000    
Maximum      
Equity, Class of Treasury Stock [Line Items]      
Stock repurchase program, authorized amount   $ 400,000,000  
v3.25.3
STOCKHOLDERS' EQUITY - Repurchases of Common Stock (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Equity [Abstract]        
Shares repurchased (in shares) 0.0 0.0 0.0 2.5
Weighted average price per share (in usd per share) $ 0 $ 0 $ 0 $ 36.20
Total cost $ 0.0 $ 0.0 $ 0.0 $ 88.7
Excise tax $ 0.0 $ 0.0 $ 0.0 $ 0.8
v3.25.3
EARNINGS PER SHARE (Details) - shares
shares in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Earnings Per Share [Abstract]        
Weighted average common shares outstanding (in shares) 50.5 51.9 50.5 52.7
Assumed exercise/vesting of equity awards (in shares) 0.0 0.0 0.0 0.0
Weighted average diluted common shares outstanding (in shares) 50.5 51.9 50.5 52.7
Equity awards, excluded from computation of diluted earnings (in shares) 1.3 0.5 1.3 0.6
v3.25.3
STOCK-BASED COMPENSATION - Additional Information (Details)
$ / shares in Units, $ in Millions
 9 Months Ended 21 Months Ended 24 Months Ended 45 Months Ended
Sep. 30, 2025
USD ($)
installment
$ / shares
shares
Sep. 30, 2025
USD ($)
shares
Dec. 31, 2023
Sep. 30, 2025
USD ($)
shares
Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period 3 years      
Award expiration period 10 years      
Stock Option | Vesting in year 1        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting percentage 33.00%      
Stock Option | Vesting in year 2        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting percentage 67.00%      
Employee Restricted Stock Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period 3 years      
Share based compensation arrangement, award vesting period, number of installments | installment 3      
Compensation costs, unrecognized | $ $ 19.9 $ 19.9   $ 19.9
Compensation costs, recognition weighted average remaining period (in years) 1 year 10 months 24 days      
Granted (in usd per share) | $ / shares $ 30.82      
Granted (in shares) 580,000      
Performance Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Compensation costs, unrecognized | $ $ 7.0 $ 7.0   $ 7.0
Compensation costs, recognition weighted average remaining period (in years) 1 year 9 months 18 days      
Granted (in usd per share) | $ / shares $ 31.68      
Granted (in shares) 246,000      
Performance Units | Executive Members        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Performance based compensation period   3 years 3 years 3 years
Accrual of units     25.00%  
Grant-date fair value (in usd per share) | $ / shares $ 38.26      
Units granted (in shares) 32,900      
Performance Units | Minimum | Executive Members        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Predefined percentage for calculation of performance unit awards   0.00%    
Predefined percentage for calculation of performance achievement unit awards   0.00% 0.00%  
Performance Units | Maximum | Executive Members        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Predefined percentage for calculation of performance unit awards   200.00%    
Predefined percentage for calculation of performance achievement unit awards   200.00% 150.00%  
TreeHouse Foods, Inc. Equity and Incentive Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Maximum number of shares available to be awarded (in shares) 22,500,000 22,500,000   22,500,000
v3.25.3
STOCK-BASED COMPENSATION - Schedule of Total Compensation Expense (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]        
Compensation expense related to stock-based payments $ 4.8 $ 4.5 $ 15.2 $ 15.5
Related income tax benefit $ 1.2 $ 1.1 $ 3.6 $ 3.7
v3.25.3
STOCK-BASED COMPENSATION - Schedule of Stock Option Activity (Details) - Stock Option - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Employee Options    
Beginning balance (in shares) 473  
Expired (in shares) (62)  
Ending balance (in shares) 411 473
Exercisable (in shares) 411  
Weighted Average Exercise Price    
Beginning balance (in usd per share) $ 61.46  
Expired (in usd per share) 78.67  
Ending balance (in usd per share) 58.87 $ 61.46
Exercisable (in usd per share) $ 58.87  
Weighted Average Remaining Contractual Term (yrs.)    
Outstanding 4 years 9 months 18 days 4 years 8 months 12 days
Exercisable 4 years 9 months 18 days  
Aggregate Intrinsic Value    
Beginning balance $ 0.0  
Ending balance 0.0 $ 0.0
Exercisable $ 0.0  
v3.25.3
STOCK-BASED COMPENSATION - Schedule of Restricted Stock and Restricted Stock Unit Activity (Details)
shares in Thousands
 9 Months Ended
Sep. 30, 2025
$ / shares
shares
Employee Restricted Stock Units  
Employee Restricted Stock Units  
Beginning balance (in shares) | shares 696
Granted (in shares) | shares 580
Vested (in shares) | shares (315)
Forfeited (in shares) | shares (196)
Ending balance (in shares) | shares 765
Weighted Average Grant Date Fair Value  
Outstanding, beginning balance (in usd per share) | $ / shares $ 38.82
Granted (in usd per share) | $ / shares 30.82
Vested (in usd per share) | $ / shares 38.15
Forfeited (in usd per share) | $ / shares 35.15
Outstanding, ending balance (in usd per share) | $ / shares $ 33.97
Non-Employee Director Restricted Stock Units  
Employee Restricted Stock Units  
Beginning balance (in shares) | shares 62
Granted (in shares) | shares 54
Vested (in shares) | shares (24)
Forfeited (in shares) | shares 0
Ending balance (in shares) | shares 92
Earned and deferred (in shares) | shares 38
Weighted Average Grant Date Fair Value  
Outstanding, beginning balance (in usd per share) | $ / shares $ 41.73
Granted (in usd per share) | $ / shares 22.29
Vested (in usd per share) | $ / shares 35.90
Forfeited (in usd per share) | $ / shares 0
Outstanding, ending balance (in usd per share) | $ / shares 31.84
Earned and deferred (in usd per share) | $ / shares $ 45.41
v3.25.3
STOCK-BASED COMPENSATION - Schedule of Employee and Director Restricted Stock and Restricted Stock Highlights (Details) - Employee Restricted Stock Units - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Fair value of vested restricted stock units $ 0.2 $ 0.4 $ 9.2 $ 10.2
Tax benefit recognized from vested restricted stock units $ 0.1 $ 0.1 $ 1.6 $ 1.7
v3.25.3
STOCK-BASED COMPENSATION - Shareholder Return Market Condition and Assumptions (Details) - Performance Units
 9 Months Ended
Sep. 30, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Dividend yield 0.00%
Risk-free rate 4.01%
Expected term (in years) 2 years 10 months 2 days
Expected volatility (TreeHouse Foods, Inc.)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expected volatility 33.68%
Expected volatility (Peer Group)  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Expected volatility 36.45%
v3.25.3
STOCK-BASED COMPENSATION - Schedule of Performance Unit Activity (Details) - Performance Units
shares in Thousands
 9 Months Ended
Sep. 30, 2025
$ / shares
shares
Performance Units  
Beginning balance (in shares) | shares 378
Granted (in shares) | shares 246
Vested (in shares) | shares (92)
Forfeited (in shares) | shares (99)
Ending balance (in shares) | shares 433
Weighted Average Grant Date Fair Value  
Outstanding, beginning balance (in usd per share) | $ / shares $ 38.04
Granted (in usd per share) | $ / shares 31.68
Vested (in usd per share) | $ / shares 33.14
Forfeited (in usd per share) | $ / shares 32.95
Outstanding, ending balance (in usd per share) | $ / shares $ 35.18
v3.25.3
STOCK-BASED COMPENSATION - Schedule of Performance Unit Highlights (Details) - Performance Units - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Fair value of vested performance units $ 0.0 $ 0.0 $ 2.4 $ 1.8
Tax benefit recognized from performance units vested $ 0.0 $ 0.0 $ 0.1 $ 0.1
v3.25.3
ACCUMULATED OTHER COMPREHENSIVE LOSS (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Beginning balance $ 1,525.1 $ 1,518.9 $ 1,548.9 $ 1,550.1 $ 1,608.1 $ 1,664.8 $ 1,548.9 $ 1,664.8
Other comprehensive income before reclassifications             3.1  
Reclassifications from accumulated other comprehensive loss             (0.1)  
Other comprehensive (loss) income (1.6) 4.4 0.2 1.5 (1.3) (2.6) 3.0 (2.4)
Ending balance 1,262.5 1,525.1 1,518.9 1,552.6 1,550.1 1,608.1 1,262.5 1,552.6
Accumulated Other Comprehensive Loss                
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Beginning balance (78.1) (82.5) (82.7) (80.0) (78.7) (76.1) (82.7) (76.1)
Other comprehensive (loss) income (1.6) 4.4 0.2 1.5 (1.3) (2.6)    
Ending balance (79.7) $ (78.1) (82.5) (78.5) $ (80.0) (78.7) (79.7) (78.5)
Foreign Currency Translation                
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Beginning balance     (92.9)     (84.2) (92.9) (84.2)
Other comprehensive income before reclassifications             3.1  
Reclassifications from accumulated other comprehensive loss             0.0  
Other comprehensive (loss) income             3.1 (2.4)
Ending balance (89.8)     (86.6)     (89.8) (86.6)
Unrecognized Pension and Postretirement Benefits                
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Beginning balance     $ 10.2     $ 8.1 10.2 8.1
Other comprehensive income before reclassifications             0.0  
Reclassifications from accumulated other comprehensive loss             (0.1)  
Other comprehensive (loss) income             (0.1) 0.0
Ending balance $ 10.1     $ 8.1     $ 10.1 $ 8.1
v3.25.3
EMPLOYEE RETIREMENT AND POSTRETIREMENT BENEFITS - Schedule of Net Periodic Pension (Benefit) Cost and Postretirement Cost (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Pension Benefits        
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]        
Service cost $ 0.1 $ 0.0 $ 0.2 $ 0.2
Interest cost 2.6 2.5 8.0 7.7
Expected return on plan assets (2.9) (2.7) (8.7) (8.1)
Amortization of unrecognized net loss 0.1 0.1 0.2 0.3
Net periodic pension (benefit) cost (0.1) (0.1) (0.3) 0.1
Postretirement Benefits        
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]        
Interest cost 0.2 0.2 0.6 0.6
Amortization of unrecognized net loss (0.1) (0.1) (0.3) (0.3)
Net periodic pension (benefit) cost $ 0.1 $ 0.1 $ 0.3 $ 0.3
v3.25.3
EMPLOYEE RETIREMENT AND POSTRETIREMENT BENEFITS - Additional Information (Details) - Subsequent Event
$ in Millions
 1 Months Ended
Oct. 31, 2025
USD ($)
retiree
Defined Benefit Plan Disclosure [Line Items]  
Settlement number of retirees impacted | retiree 800
Pension Benefits  
Defined Benefit Plan Disclosure [Line Items]  
Benefit obligation, payment for settlement $ 80.0
Plan assets payment for settlement 74.0
Non-cash settlement gain $ 8.5
v3.25.3
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 9 Months Ended 10 Months Ended 24 Months Ended
Nov. 10, 2025
Sep. 30, 2025
Sep. 30, 2025
Nov. 10, 2025
Sep. 30, 2025
Dec. 31, 2024
Aug. 31, 2020
Loss Contingencies [Line Items]              
Gain contingency             $ 358.0
Minimum              
Loss Contingencies [Line Items]              
Gain contingency             719.4
Maximum              
Loss Contingencies [Line Items]              
Gain contingency             $ 1,500.0
Damages from Product Defects | Brantford, Ontario, Canada              
Loss Contingencies [Line Items]              
Product recall liability   $ 14.5 $ 14.5   $ 14.5 $ 9.6  
Insurance recoveries   13.0 23.0        
Damages from Product Defects | Brantford, Ontario, Canada | Subsequent Event              
Loss Contingencies [Line Items]              
Insurance recoveries $ 7.0     $ 30.0      
Damages from Product Defects | Cambridge, Maryland              
Loss Contingencies [Line Items]              
Insurance recoveries   $ 4.5 $ 7.6   $ 17.6    
v3.25.3
DERIVATIVE INSTRUMENTS - Additional Information (Details) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Interest Rate Swap Agreements    
Derivative [Line Items]    
Derivative notional amount $ 875,000,000.0 $ 1,750,000,000
Interest Rate Swaps Effective February 28, 2025 Through February 29, 2028    
Derivative [Line Items]    
Derivative notional amount $ 875,000,000.0  
Weighted average fixed interest rate 3.69%  
Diesel Contract    
Derivative [Line Items]    
Derivative, nonmonetary notional amount 91,000,000.0 61,500,000
v3.25.3
DERIVATIVE INSTRUMENTS - Fair Value of Derivative Instrument (Details) - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Derivatives, Fair Value [Line Items]    
Asset derivatives $ 7.3 $ 18.9
Liability derivatives 7.8 0.4
Commodity contracts | Prepaid expenses and other current assets    
Derivatives, Fair Value [Line Items]    
Asset derivatives 7.3 9.1
Commodity contracts | Accrued expenses    
Derivatives, Fair Value [Line Items]    
Liability derivatives 0.3 0.0
Interest rate swap agreements | Prepaid expenses and other current assets    
Derivatives, Fair Value [Line Items]    
Asset derivatives 0.0 2.2
Interest rate swap agreements | Other assets, net    
Derivatives, Fair Value [Line Items]    
Asset derivatives 0.0 7.6
Interest rate swap agreements | Accrued expenses    
Derivatives, Fair Value [Line Items]    
Liability derivatives $ 7.5 $ 0.4
v3.25.3
DERIVATIVE INSTRUMENTS - Gains and Losses on Derivative Contracts (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Derivative Instruments, Gain (Loss) [Line Items]        
Mark-to-market unrealized gain (loss), derivative     $ (19.0) $ (11.0)
Total unrealized gain (loss) $ 12.7 $ (19.5) (19.0) (11.0)
Total realized (loss) gain (2.1) 6.6 12.7 21.6
Total gain (loss) 10.6 (12.9) (6.3) 10.6
Commodity contracts | Other (income) expense, net        
Derivative Instruments, Gain (Loss) [Line Items]        
Mark-to-market unrealized gain (loss), commodity contracts 13.2 6.5 (2.1) 8.4
Commodity contracts | Manufacturing-related to Cost of sales and transportation-related to Selling and distribution        
Derivative Instruments, Gain (Loss) [Line Items]        
Total realized (loss) gain (3.6) 0.8 7.1 4.6
Interest rate swap agreements | Other (income) expense, net        
Derivative Instruments, Gain (Loss) [Line Items]        
Mark-to-market unrealized gain (loss), derivative (0.5) (26.0) (16.9) (19.4)
Interest rate swap agreements | Interest expense        
Derivative Instruments, Gain (Loss) [Line Items]        
Total realized (loss) gain $ 1.5 $ 5.8 $ 5.6 $ 17.0
v3.25.3
SEGMENT INFORMATION - Additional Information (Details)
 9 Months Ended
Sep. 30, 2025
segment
segment_manager
Segment Reporting [Abstract]  
Number of reportable segments | segment 1
Number of segment managers | segment_manager 1
v3.25.3
SEGMENT INFORMATION - Schedule of Reported Segment Revenue, Profit or Loss and Significant Segment Expenses (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting Information [Line Items]                
Net sales $ 840.3     $ 839.1     $ 2,430.3 $ 2,448.3
Cost of sales 682.4     707.9     2,018.0 2,076.8
Amortization expense 13.0     12.3     39.3 36.5
Impairment 289.7     0.0 $ 19.3   289.7 19.3
Other operating expense, net 27.2     5.1     55.1 22.7
Total other expense 13.4     36.1     84.4 63.1
Income tax benefit (1.7)     (0.9)     (16.2) (8.7)
Net loss (265.8) $ (2.9) $ (31.8) (3.4) $ (16.7) $ (11.7) (300.5) (31.8)
Reportable Segment                
Segment Reporting Information [Line Items]                
Net sales 840.3     839.1     2,430.3 2,448.3
Cost of sales 682.4     707.9     2,018.0 2,076.8
Freight out and commissions 28.1     27.4     78.9 84.0
Direct selling, general, and administrative 14.7     8.8     49.3 28.6
Corporate selling, general, and administrative 39.3     45.8     132.3 157.8
Amortization expense 13.0     12.3     39.3 36.5
Impairment 289.7     0.0     289.7 19.3
Other operating expense, net 27.2     5.1     55.1 22.7
Total other expense 13.4     36.1     84.4 63.1
Income tax benefit (1.7)     (0.9)     (16.2) (8.7)
Net loss $ (265.8)     $ (3.4)     $ (300.5) $ (31.8)
v3.25.3
SEGMENT INFORMATION - Schedule of Segment Revenue Disaggregated by Product Category and Sales Channel (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting Information [Line Items]        
Net sales $ 840.3 $ 839.1 $ 2,430.3 $ 2,448.3
Retail grocery        
Segment Reporting Information [Line Items]        
Net sales 670.6 674.2 1,920.6 1,931.6
Co-manufacturing        
Segment Reporting Information [Line Items]        
Net sales 84.4 95.0 259.8 299.2
Food-away-from-home and other        
Segment Reporting Information [Line Items]        
Net sales 85.3 69.9 249.9 217.5
Snacking        
Segment Reporting Information [Line Items]        
Net sales 300.6 318.2 855.4 941.9
Beverages & drink mixes        
Segment Reporting Information [Line Items]        
Net sales 316.4 281.7 905.4 793.9
Grocery        
Segment Reporting Information [Line Items]        
Net sales $ 223.3 $ 239.2 $ 669.5 $ 712.5
v3.25.3
SUBSEQUENT EVENT (Details) - Subsequent Event
$ / shares in Units, $ in Billions
Nov. 10, 2025
USD ($)
$ / shares
Subsequent Event [Line Items]  
Price per share to be received (in dollars per share) | $ / shares $ 22.50
Enterprise Value | $ $ 2.9
Contingent Value Right 1